<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Physiology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31114506</article-id>
<article-id pub-id-type="pmc">6503037</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2019.00479</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Neuronal Redox-Imbalance in Rett Syndrome Affects Mitochondria as Well as Cytosol, and Is Accompanied by Intensified Mitochondrial O<sub><italic>2</italic></sub> Consumption and ROS Release</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Can</surname>
<given-names>Karolina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/576084/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Menzfeld</surname>
<given-names>Christiane</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rinne</surname>
<given-names>Lena</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rehling</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kügler</surname>
<given-names>Sebastian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/11609/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Golubiani</surname>
<given-names>Gocha</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dudek</surname>
<given-names>Jan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/418337/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Müller</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/47316/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Georg-August-University Göttingen</institution>, <addr-line>Göttingen</addr-line>, <country>Germany</country></aff>
<aff id="aff2"><sup>2</sup><institution>Zentrum Physiologie und Pathophysiologie, Institut für Neuro- und Sinnesphysiologie, Universitätsmedizin Göttingen, Georg-August-Universität Göttingen</institution>, <addr-line>Göttingen</addr-line>, <country>Germany</country></aff>
<aff id="aff3"><sup>3</sup><institution>Zentrum Biochemie und Molekulare Zellbiologie, Institut für Zellbiochemie, Universitätsmedizin Göttingen, Georg-August-Universität Göttingen</institution>, <addr-line>Göttingen</addr-line>, <country>Germany</country></aff>
<aff id="aff4"><sup>4</sup><institution>Klinik für Neurologie, Universitätsmedizin Göttingen, Georg-August-Universität Göttingen</institution>, <addr-line>Göttingen</addr-line>, <country>Germany</country></aff>
<aff id="aff5"><sup>5</sup><institution>Institute of Chemical Biology, Ilia State University</institution>, <addr-line>Tbilisi</addr-line>, <country>Georgia</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Gareth Davison, Ulster University, United Kingdom</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Richard Eugene Frye, Phoenix Children’s Hospital, United States; Yeong-Renn Chen, Northeast Ohio Medical University, United States; Marcos Lopez, The University of Chicago, United States</p>
</fn>
<corresp id="c001">*Correspondence: Michael Müller, <email>mmuelle7@gwdg.de</email></corresp>
<fn fn-type="other" id="fn002">
<p><sup>†</sup>These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn003">
<p>This article was submitted to Oxidant Physiology, a section of the journal Frontiers in Physiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>10</volume>
<elocation-id>479</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>4</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Can, Menzfeld, Rinne, Rehling, Kügler, Golubiani, Dudek and Müller.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Can, Menzfeld, Rinne, Rehling, Kügler, Golubiani, Dudek and Müller</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Rett syndrome (RTT), an X chromosome-linked neurodevelopmental disorder affecting almost exclusively females, is associated with various mitochondrial alterations. Mitochondria are swollen, show altered respiratory rates, and their inner membrane is leaking protons. To advance the understanding of these disturbances and clarify their link to redox impairment and oxidative stress, we assessed mitochondrial respiration in defined brain regions and cardiac tissue of male wildtype (WT) and MeCP2-deficient (<italic>Mecp2<sup>-/y</sup></italic>) mice. Also, we quantified for the first time neuronal redox-balance with subcellular resolution in cytosol and mitochondrial matrix. Quantitative roGFP1 redox imaging revealed more oxidized conditions in the cytosol of <italic>Mecp2<sup>-/y</sup></italic> hippocampal neurons than in WT neurons. Furthermore, cytosol and mitochondria of <italic>Mecp2<sup>-/y</sup></italic> neurons showed exaggerated redox-responses to hypoxia and cell-endogenous reactive oxygen species (ROS) formation. Biochemical analyzes exclude disease-related increases in mitochondrial mass in <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex. Protein levels of complex I core constituents were slightly lower in <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex than in WT; those of complex V were lower in <italic>Mecp2<sup>-/y</sup></italic> cortex. Respiratory supercomplex-formation did not differ among genotypes. Yet, supplied with the complex II substrate succinate, mitochondria of <italic>Mecp2<sup>-/y</sup></italic> cortex and hippocampus consumed more O<sub>2</sub> than WT. Furthermore, mitochondria from <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex mediated an enhanced oxidative burden. In conclusion, we further advanced the molecular understanding of mitochondrial dysfunction in RTT. Intensified mitochondrial O<sub>2</sub> consumption, increased mitochondrial ROS generation and disturbed redox balance in mitochondria and cytosol may represent a causal chain, which provokes dysregulated proteins, oxidative tissue damage, and contributes to neuronal network dysfunction in RTT.</p>
</abstract>
<kwd-group>
<kwd>oxidative stress</kwd>
<kwd>reactive oxygen species</kwd>
<kwd>disease progression</kwd>
<kwd>methyl-CpG binding protein 2 encoding gene (mouse)</kwd>
<kwd>hippocampus</kwd>
<kwd>cortex</kwd>
<kwd>heart</kwd>
<kwd>reduction-oxidation sensitive green fluorescent protein 1</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Deutsche Forschungsgemeinschaft<named-content content-type="fundref-id">10.13039/501100001659</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn002">International Rett Syndrome Foundation<named-content content-type="fundref-id">10.13039/100001819</named-content></funding-source>
<award-id rid="cn002">2817</award-id>
</award-group>
<award-group>
<funding-source id="cn003">Volkswagen Foundation<named-content content-type="fundref-id">10.13039/501100001663</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn004">Shota Rustaveli National Science Foundation<named-content content-type="fundref-id">10.13039/501100004801</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="7"></fig-count>
<table-count count="0"></table-count>
<equation-count count="2"></equation-count>
<ref-count count="76"></ref-count>
<page-count count="18"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Rett syndrome (RTT) is a progressive neurodevelopmental disorder. It primarily affects females, who show the first obvious symptoms within 6–18 months after birth. Among the characteristics are a regression of mental and physical development as well as severe disabilities such as breathing disturbances, loss of speech, autistic features, cognitive impairment, and epilepsy (<xref ref-type="bibr" rid="B51">Rett, 1966</xref>; <xref ref-type="bibr" rid="B32">Hagberg et al., 1983</xref>; <xref ref-type="bibr" rid="B11">Chahrour and Zoghbi, 2007</xref>). In the majority of cases, RTT is caused by spontaneous mutations in the X-chromosomal <italic>MECP2</italic> gene encoding for the transcriptional regulator MeCP2 (<xref ref-type="bibr" rid="B1">Amir et al., 1999</xref>).</p>
<p>Patient and rodent studies confirm that mitochondria are morphologically and functionally affected in RTT (<xref ref-type="bibr" rid="B25">Eeg-Olofsson et al., 1990</xref>; <xref ref-type="bibr" rid="B6">Belichenko et al., 2009</xref>; <xref ref-type="bibr" rid="B30">Großer et al., 2012</xref>; <xref ref-type="bibr" rid="B29">Gold et al., 2014</xref>; <xref ref-type="bibr" rid="B49">Park et al., 2014</xref>; <xref ref-type="bibr" rid="B63">Valenti et al., 2014</xref>; <xref ref-type="bibr" rid="B59">Shulyakova et al., 2017</xref>). Human skeletal muscle and frontal lobe biopsy samples revealed swollen mitochondria with vacuolizations and granular inclusions (<xref ref-type="bibr" rid="B56">Ruch et al., 1989</xref>; <xref ref-type="bibr" rid="B25">Eeg-Olofsson et al., 1990</xref>; <xref ref-type="bibr" rid="B14">Cornford et al., 1994</xref>). In male Rett mice carrying a knockout mutation of the <italic>Mecp2</italic> gene (<italic>Mecp2<sup>-/y</sup></italic> mice), we previously observed that hippocampal mitochondria show less negative membrane potentials and increased FAD/NADH baseline-ratios, which indicates an intensified degree of oxidation and increased levels of ROS (<xref ref-type="bibr" rid="B30">Großer et al., 2012</xref>; <xref ref-type="bibr" rid="B46">Müller and Can, 2014</xref>). Also, brain ATP content is affected. Higher resting ATP levels with increased ATP turnover rates were reported for neonatal hippocampal <italic>Mecp2<sup>-/y</sup></italic> neurons (<xref ref-type="bibr" rid="B62">Toloe et al., 2014</xref>), whereas whole brain studies on adult symptomatic male and female Rett mice detected reduced ATP concentrations (<xref ref-type="bibr" rid="B57">Saywell et al., 2006</xref>; <xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>; <xref ref-type="bibr" rid="B64">Valenti et al., 2017</xref>).</p>
<p>In view of these findings, also specific changes in mitochondrial respiration are to be expected. The mitochondrial respiratory chain consists of four complexes, CI, CII, CIII, and CIV, which are transporting electrons from reducing equivalents (NADH+H<sup>+</sup>, FADH<sub>2</sub>) to molecular oxygen. This electron transport extrudes protons across the inner membrane, and the resulting membrane potential then drives ATP synthesis by the F<sub>1</sub>F<sub>o</sub>-ATP synthase (CV) (<xref ref-type="bibr" rid="B44">Mitchell, 1961</xref>). Indeed, Rett patients show lower expression levels of cytochrome <italic>c</italic> oxidase subunit I as well as reduced enzymatic activities of cytochrome <italic>c</italic> oxidase and succinate cytochrome <italic>c</italic> reductase (<xref ref-type="bibr" rid="B13">Coker and Melnyk, 1991</xref>; <xref ref-type="bibr" rid="B28">Gibson et al., 2010</xref>). Also in Rett mice, lowered enzymatic activities of the respiratory complexes are evident in brain and skeletal muscle (<xref ref-type="bibr" rid="B38">Kriaucionis et al., 2006</xref>; <xref ref-type="bibr" rid="B29">Gold et al., 2014</xref>; <xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>; <xref ref-type="bibr" rid="B64">Valenti et al., 2017</xref>). In concert with altered O<sub>2</sub> consumption rates (<xref ref-type="bibr" rid="B38">Kriaucionis et al., 2006</xref>) these changes may easily culminate in reduced brain ATP contents (<xref ref-type="bibr" rid="B57">Saywell et al., 2006</xref>; <xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>; <xref ref-type="bibr" rid="B64">Valenti et al., 2017</xref>).</p>
<p>Nevertheless, detailed information on the very brain regions affected and on the exact time course of mitochondrial changes in RTT is sparse. Another issue still to be addressed, is whether besides differential protein levels and activities also altered protein/protein interactions may contribute to the mitochondrial dysfunction in RTT. The mitochondrial respiratory chain forms large supercomplexes in which CI binds to a dimer of CIII and several copies of CIV (<xref ref-type="bibr" rid="B58">Schägger and Pfeiffer, 2000</xref>; <xref ref-type="bibr" rid="B39">Lenaz and Genova, 2012</xref>; <xref ref-type="bibr" rid="B74">Wu et al., 2016</xref>). This supercomplex formation guarantees an efficient energy transduction within the respiratory chain, prevents energy leakage, and dampens ROS production. Pathological changes in supercomplex structure were reported for many disease models (<xref ref-type="bibr" rid="B68">Wallace, 1999</xref>; <xref ref-type="bibr" rid="B20">DiMauro and Schon, 2003</xref>; <xref ref-type="bibr" rid="B48">Pacheu-Grau et al., 2015</xref>; <xref ref-type="bibr" rid="B23">Dudek et al., 2016</xref>) – but at present it is unclear whether this may be the case also in RTT.</p>
<p>Another aspect is that mitochondria are a prominent source of ROS. During electron transport from CI to CIV approximately 2–5% of electrons escape and diffuse directly to O<sub>2</sub>, thereby generating superoxide (<xref ref-type="bibr" rid="B8">Boveris and Chance, 1973</xref>; <xref ref-type="bibr" rid="B65">Votyakova and Reynolds, 2001</xref>; <xref ref-type="bibr" rid="B9">Brand, 2010</xref>). Hence, the increased mitochondrial activity and ATP turnover in Rett mice (<xref ref-type="bibr" rid="B38">Kriaucionis et al., 2006</xref>; <xref ref-type="bibr" rid="B30">Großer et al., 2012</xref>; <xref ref-type="bibr" rid="B62">Toloe et al., 2014</xref>) should be associated with increased ROS generation. Indeed, an intensified H<sub>2</sub>O<sub>2</sub> production was observed in isolated mitochondria of female Rett mouse brains (<xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>; <xref ref-type="bibr" rid="B64">Valenti et al., 2017</xref>). It appears to contribute to the systemic oxidative burden and the oxidative tissue damage in RTT (<xref ref-type="bibr" rid="B15">De Felice et al., 2009</xref>; <xref ref-type="bibr" rid="B16">De Felice et al., 2014</xref>), which is assumed to drive the disease progression in RTT (<xref ref-type="bibr" rid="B17">De Felice et al., 2012</xref>; <xref ref-type="bibr" rid="B30">Großer et al., 2012</xref>; <xref ref-type="bibr" rid="B46">Müller and Can, 2014</xref>; <xref ref-type="bibr" rid="B45">Müller, 2019</xref>). Yet again, these studies were performed on full brain and do not provide any brain region-specific or even subcellular insights. Furthermore, it still has to be clarified in detail, how the mitochondrial alterations are mechanistically linked to redox-imbalance, oxidative stress, and neuronal network dysfunction in RTT.</p>
<p>Therefore, we took a closer look at redox balance specifically in neurons, and we quantified redox conditions in their cytosolic and mitochondrial compartment, by using the advanced, genetically encoded redox sensor roGFP1. Furthermore, we assessed multiple aspects of mitochondrial physiology in defined brain regions of Rett mice to unravel the interplay of mitochondrial alterations and cellular redox balance in this neurodevelopmental disorder. In particular, we focused on hippocampal and cortical tissue, as these brain areas are metabolically highly demanding, very vulnerable to oxidative stress, and essentially underlie complex cognitive functions. By means of quantitative redox imaging and comprehensive biochemical protein analyzes, we confirm that the redox impairment in RTT affects neuronal cytosol as well as mitochondrial matrix. Only moderate decreases in the expression of respiratory complex constituents were evident in mitochondria of <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex. Nevertheless, their O<sub>2</sub> consumption rate was increased in the presence of CII substrates. Also, an intensified ROS generation was confirmed for mitochondria of <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex.</p>
</sec>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<p>As a mouse model for RTT, we chose <italic>Mecp2</italic> knockout mice [B6.129P2(C)-<italic>Mecp2<sup>tm1.1Bird</sup></italic>] (<xref ref-type="bibr" rid="B31">Guy et al., 2001</xref>). In order to ensure uniform conditions, i.e., a total lack of MeCP2 in each single cell studied by our cell-based and tissue analyzes, only male Rett mice (<italic>Mecp2<sup>-/y</sup></italic>) were used. They develop symptoms earlier, present a more severe phenotype, and were compared with their male WT siblings. Optimized breeding of Rett mice could be achieved with WT (NMRI line) foster mice only, which took better care of the offspring than the female Rett mice (<italic>Mecp2<sup>+/-</sup></italic>). All experiments were in accordance with German regulations and authorized by the Office of Animal Welfare of the University Medical Center Göttingen as well as by the Lower Saxony State Office for Consumer Protection and Food Safety. Mouse genotypes were disclosed only after data collection and analysis. Yet, for <italic>Mecp2<sup>-/y</sup></italic> mice, the genotype eventually became obvious due to their characteristic phenotype and behavior.</p>
<sec>
<title>Solutions</title>
<p>Unless stated differently, all chemicals were obtained from Sigma-Aldrich. Growth medium used for organotypic slice cultures consisted of minimum essential medium (MEM, Invitrogen) supplemented with 5% FCS, 0.5 mM L-glutamine, 20 μl/ml B27 50× supplement (Invitrogen), 2 μM cytosine arabinoside, and 100 μg/ml penicillin-streptomycin (Biochrom). ACSF contained 130 mM NaCl, 3.5 mM KCl, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 24 mM NaHCO<sub>3</sub>, 1.2 mM CaCl<sub>2</sub>, 1.2 mM MgSO<sub>4</sub> and 10 mM dextrose, and was aerated constantly with 95% O<sub>2</sub> plus 5% CO<sub>2</sub> (carbogen) to ensure a stable pH of 7.4 as well as a proper O<sub>2</sub> supply of the tissue under investigation. The redox stimulants H<sub>2</sub>O<sub>2</sub> (30% aqueous stock solution), DEDTC, and 1,4-dithio-DL threitol (DTT, Fluka) were added to the ACSF immediately before use. AMC was first dissolved as 20 mM stock solution in absolute ethanol and stored at -20°C. The oxidation-sensitive dyes H<sub>2</sub>DCFDA (2′,7′-dichlorodihydrofluorescein diacetate, Invitrogen) and Amplex UltraRed (Invitrogen) were dissolved in dimethyl sulfoxide as 100 mM and 10 mM stock solutions, respectively, and stored at -20°C.</p>
</sec>
<sec>
<title>Hippocampal Slice Cultures</title>
<p>Organotypic slice cultures were prepared from neonatal male mice at PD 3–5, as described earlier (<xref ref-type="bibr" rid="B61">Stoppini et al., 1991</xref>; <xref ref-type="bibr" rid="B30">Großer et al., 2012</xref>). After decapitation, the brain was removed and placed in ice-cold Hanks’ balanced salt solution. Isolated hippocampi were cut into 350 μm-thick slices (McIlwain tissue chopper, Stoelting Co.), placed on the membranes of six-well culture plates (Transwell Permeable Support, Corning), and incubated under interface conditions at 37°C in a 5% CO<sub>2</sub>-atmosphere. Each well contained 1 ml growth medium, half of which was replaced every 2–3 days.</p>
</sec>
<sec>
<title>Optical Recordings and Transduction Procedures</title>
<p>Cellular redox conditions were monitored with a CCD-camera imaging system. It was controlled by TILLvisION 4.0.1 software (TILL Photonics) and consisted of a xenon light source (Polychrome II; Till Photonics), a sensitive CCD camera (Imago QE; PCO Imaging), and an upright fluorescence microscope (Axioskop I; Zeiss) with a 63× 1.0 NA water immersion objective (Plan-Apochromat; Zeiss). For the imaging experiments, slice cultures were placed with their support membranes in a submersion-style chamber and superfused with pre-warmed ACSF (37°C, 4.5 ml/min).</p>
<p>Neuronal redox balance was quantified with the excitation-ratiometric optical redox sensor roGFP1 (<xref ref-type="bibr" rid="B21">Dooley et al., 2004</xref>; <xref ref-type="bibr" rid="B33">Hanson et al., 2004</xref>). This optical probe does not detect a particular reactive oxygen or nitrogen species, but rather reports thiol redox balance, and it responds reversibly to redox modulation. Hence, roGFP1 senses – similar to numerous other cellular proteins (<xref ref-type="bibr" rid="B71">Weerapana et al., 2010</xref>) – the subcellular thiol redox conditions. In detail, oxidation increases light absorption at 390 nm and decreases absorption at 470 nm; reduction causes opposite responses. Therefore, we excited roGFP1 alternatingly at 395 and 470 nm, and calculated the resulting fluorescence ratio R (<xref ref-type="bibr" rid="B27">Funke et al., 2011</xref>; <xref ref-type="bibr" rid="B30">Großer et al., 2012</xref>); as optical filters we chose a 460–480 nm bandpass excitation filter, a 495 nm dichroic mirror, and a 525–550 nm bandpass emission filter. Among the advantages of this excitation-ratiometric approach are highly stable recordings as well as improved response dynamics, and the ratiometric redox responses obtained are independent of the expression level of the redox sensor. Nevertheless, quantitative analyses demand that those roGFP1 ratios are determined which correspond to full oxidation (R<sub>ox</sub>) and full reduction (R<sub>red</sub>), as induced by saturating doses of H<sub>2</sub>O<sub>2</sub> (5 mM), and DTT (10 mM), respectively (<xref ref-type="bibr" rid="B33">Hanson et al., 2004</xref>; <xref ref-type="bibr" rid="B27">Funke et al., 2011</xref>; <xref ref-type="bibr" rid="B67">Wagener et al., 2016</xref>). Once calibrated, the relative degree of oxidation OxD<sub>roGFP1</sub> can be determined for the respective experimental conditions [see (<xref ref-type="bibr" rid="B43">Meyer and Dick, 2010</xref>)]:</p>
<disp-formula id="E1">
<mml:math id="M1">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mtext>OxD</mml:mtext>
</mml:mrow>
<mml:mrow>
<mml:mtext>roGFP</mml:mtext>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mtext>R</mml:mtext>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mtext>R</mml:mtext>
<mml:mrow>
<mml:mtext>red</mml:mtext>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mtext>F</mml:mtext>
<mml:msub>
<mml:mrow>
<mml:mn>470</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mtext>ox</mml:mtext>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:mtext>F</mml:mtext>
<mml:msub>
<mml:mrow>
<mml:mn>470</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mtext>red</mml:mtext>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mtext> </mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="italic">R</mml:mi>
<mml:mrow>
<mml:mi mathvariant="italic">o</mml:mi>
<mml:mi mathvariant="italic">x</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>−</mml:mo>
<mml:mi mathvariant="italic">R</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mtext> </mml:mtext>
<mml:mo>+</mml:mo>
<mml:mtext> </mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi mathvariant="italic">R</mml:mi>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">R</mml:mi>
<mml:mrow>
<mml:mi mathvariant="italic">r</mml:mi>
<mml:mi mathvariant="italic">e</mml:mi>
<mml:mi mathvariant="italic">d</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
<p>Based on OxD<sub>roGFP1</sub> and the standard redox potential of roGFP1 (E<sup>0</sup>′ = -291 mV), the Nernst equation then yields the corresponding roGFP1 redox potentials (<xref ref-type="bibr" rid="B33">Hanson et al., 2004</xref>; <xref ref-type="bibr" rid="B43">Meyer and Dick, 2010</xref>; <xref ref-type="bibr" rid="B67">Wagener et al., 2016</xref>):</p>
<disp-formula id="E2">
<mml:math id="M2">
<mml:mrow>
<mml:msub>
<mml:mtext>E</mml:mtext>
<mml:mrow>
<mml:mtext>roGFP</mml:mtext>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:msup>
<mml:mtext>E</mml:mtext>
<mml:mn>0</mml:mn>
</mml:msup>
<mml:mtext>′roGFP</mml:mtext>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mtext>RT</mml:mtext>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
<mml:mtext>F</mml:mtext>
</mml:mrow>
</mml:mfrac>
<mml:mtext>ln</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mtext>OxD</mml:mtext>
</mml:mrow>
<mml:mrow>
<mml:mtext>roGFP</mml:mtext>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mtext>OxD</mml:mtext>
</mml:mrow>
<mml:mrow>
<mml:mtext>roGFP</mml:mtext>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
<p>After confirming reliable responses of roGFP1 in hippocampal cells and slices (<xref ref-type="bibr" rid="B27">Funke et al., 2011</xref>; <xref ref-type="bibr" rid="B30">Großer et al., 2012</xref>), we developed viral constructs (AAV6) and placed roGFP1 under the human synapsin 1 promoter, to optimize the transduction efficiency and to ensure a neuron-specific expression. Without further targeting sequences, roGFP1 is expressed in the cytosol (cyto-roGFP1). Its reliable expression in mitochondrial matrix (mito-roGFP1) is guaranteed by the included mitochondrial targeting sequence of subunit VIII of cytochrome <italic>c</italic> oxidase (<xref ref-type="bibr" rid="B10">Can et al., 2017</xref>). Slice cultures were transduced on DIV 3–4, by applying 2.5 μl of the vector (1:50 dilution in PBS; undiluted titer 1.3 × 10<sup>8</sup> particles/μl) onto each slice. Redox imaging experiments were then performed between DIV 9–15.</p>
</sec>
<sec>
<title>Tissue Preparation From Adult Mice</title>
<p>Adult male mice (PD43-49) were ether anesthetized, decapitated, and the brain removed as described earlier (<xref ref-type="bibr" rid="B26">Fischer et al., 2009</xref>). The heart was isolated as well, and the collected tissue was processed further to prepare mitochondrial suspensions. Excess tissue was cryopreserved in liquid N<sub>2</sub> and stored at -80°C for later use.</p>
</sec>
<sec>
<title>Mitochondrial Suspensions</title>
<p>Mitochondrial isolation was performed as described before, with some modifications (<xref ref-type="bibr" rid="B2">Argan et al., 1983</xref>). The rigid cardiac tissue was first sliced into small pieces, transferred into 1 ml isolation buffer and minced in a blender (Ultra Thurax T8, IKA Labortechnik). Hippocampal and cortical tissue was transferred into isolation buffer (20 mM HEPES pH 7.6, 220 mM mannitol, 70 mM sucrose, 1 mM 2,2′,2′′,2′′′-(1,2-ethanediyldinitrilo)-tetraacetic acid (EDTA), 0.5 mM PMSF, and homogenized (Potter S, Sartorius) at 1 × 300, 1 × 500, and 25 × 700 rpm. After removing cell debris by centrifugation (800 g, 15 min, 4°C) supernatants were pooled and centrifuged again for 30 min to remove remaining debris. Part of the supernatant was cryopreserved as whole-cell lysate for later protein analyzes. Remaining supernatant was centrifuged at 10,000 g (10 min, 4°C) to spin down the mitochondrial fraction, and the pellets were resuspended in isolation buffer. Final volume and protein amounts were determined by Bradford assay.</p>
</sec>
<sec>
<title>Protein Analysis</title>
<p>Proteins of whole cellular lysates were separated by SDS-PAGE (12.5% SDS-PAGE), loading 10–20 μg/lane protein. Blue native (BN) gel electrophoresis was performed as reported earlier (<xref ref-type="bibr" rid="B72">Wittig et al., 2006</xref>; <xref ref-type="bibr" rid="B66">Vukotic et al., 2012</xref>). For Western blot analysis 30 μg/lane of isolated mitochondria were used. In-gel activity staining required higher protein amounts (CI: 50 μg/lane, CIV: 100 μg/lane, and CV: 150 μg/lane). Mitochondrial membranes were solubilized in lysis buffer [20 mM Tris/HCl pH7.4, 0.1 mM EDTA, 50 mM NaCl, 10% (v/v) glycerol, 1% (w/v) digitonin, 1 mM PMSF] and incubated for 30 min at 4°C while shaking constantly. Non-solubilized material was removed by centrifugation (Eppendorf 5415R, 16,000 g, 5 min, 4°C). Supernatants were transferred into a new sample tube and mixed with 10× loading buffer [5% (w/v) Coomassie Brilliant Blue G-250, 500 mM 𝜀-amino-n-caproic acid diluted in 100 mM Bis-Tris pH7.0]. Samples were separated on a 4–14% poly-acrylamide gradient gel, using a cathode buffer (50 mM Tricine pH7.0, 15 mM Bis-Tris, 0.02% Coomassie G-250) and an anode buffer (50 mM Bis-Tris/HCl pH7.0) (<xref ref-type="bibr" rid="B19">Dekker et al., 1997</xref>).</p>
<p>For Western blots, standard methods were used to transfer proteins to polyvinylidene fluoride membranes. After blocking (5% skimmed milk diluted in TBS containing 0.1% Tween), membranes were probed with primary antibodies. Anti-NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8 (NDUFB8), anti-succinate dehydrogenase A (SDHA, Cell Signaling Technology), anti-ubiquinol-cytochrome <italic>c</italic> reductase, Rieske iron-sulfur polypeptide 1 (Rieske), anti-cytochrome <italic>c</italic> oxidase subunit I (COX1), ATP synthase subunit beta (AtpB, Antikoerper-online), and anti-VDAC3 were produced in rabbit. Anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 5G4-6C5, Biotrend) was produced in mice. Secondary antibodies were coupled to horseradish peroxidase (Dianova). Chemiluminescence (ECL<sup>TM</sup> Western blot detection reagent, GE or Clarity<sup>TM</sup> Western ECL substrate, BioRad) was detected using films (Medix XBU Medical X-Ray Film, Foma Bohemia) or imaged with a camera (Image Reader LAS-1000, Fujifilm). Signal intensities were analyzed by Aida Image Analyzer V.3.10.</p>
<p>In-gel catalytic activity of native respiratory chain complexes separated by BN-PAGE was rated as reported earlier (<xref ref-type="bibr" rid="B75">Zerbetto et al., 1997</xref>; <xref ref-type="bibr" rid="B73">Wittig et al., 2007</xref>). CI activity was visualized with 2.5 mg/ml NTB in staining solution (0.1 mg/ml NADH and 5 mM Tris, pH 7.4) at 37°C until staining became visible. For CIV staining, cytochrome <italic>c</italic>, reduced with 15 mg/ml Na-dithionite, was added at a concentration of 1 mg/ml to the staining solution containing 0.5 mg/ml diaminobenzidine in 50 mM KPi, pH 7.4. CV staining was performed in 35 mM Tris–HCl pH 8.3, 270 mM glycine, 14 mM MgSO<sub>4</sub> 0.2% Pb(NO<sub>3</sub>)<sub>2</sub>, and 8 mM ATP. Band intensities were quantified by ImageQuant TL 1D Version 7.0 (GE Health Care).</p>
</sec>
<sec>
<title>Mitochondrial O<sub>2</sub> Consumption</title>
<p>For quantitative analysis of O<sub>2</sub> consumption, a Seahorse XF96 Extracellular Flux Analyzer (Seahorse Bioscience) was used. Isolated mitochondria were resuspended in assay buffer (MAS, 70 mM sucrose, 220 mM mannitol, 2 mM HEPES, 10 mM KH<sub>2</sub>PO<sub>4</sub>, 5 mM MgCl<sub>2</sub>, 1 mM EGTA, and 0.2% BSA, pH 7.4), and loaded to a 96-well sample plate. A centrifugation step (2,000 g, 20 min, 4°C, Allegra X-15R, Beckman Coulter) ensured that mitochondria adhered to the bottom of the wells. Basal respiration was measured at 37°C, in 180 μl MAS containing 2 mM malate + 10 mM pyruvate or 4 mM succinate as substrate. Subsequent consecutive measurements were performed after reoxygenation and automated administration of 12 mM ADP, 1.5 μM oligomycin, 4 μM FCCP, and 4 μM antimycin A + 2 μM rotenone. Data were analyzed with the XF96 Software (Version 1.3.0.79).</p>
</sec>
<sec>
<title>ROS Formation by Isolated Mitochondria</title>
<p>Mitochondrial ROS formation was probed with the oxidation-sensitive dyes H<sub>2</sub>DCFDA (100 μM) and Amplex UltraRed (10 μM). These cuvette assays are standard approaches, which define ROS formation in response to mitochondrial challenges and/or in transgenic mouse models (<xref ref-type="bibr" rid="B41">Mattiasson, 2004</xref>; <xref ref-type="bibr" rid="B53">Rönnbäck et al., 2016</xref>). In the case of AmplexRed, H<sub>2</sub>O<sub>2</sub> is detected in a coupled reaction with horseradish peroxidase (1 U/ml) (<xref ref-type="bibr" rid="B76">Zhou et al., 1997</xref>; <xref ref-type="bibr" rid="B37">Komary et al., 2010</xref>). Isolated mitochondria (40 μg) were resuspended in MAS buffer for native conditions or in a denaturing buffer (20 mM Tris, 150 mM NaCl, 0.1% Triton, pH 7.4). The oxidation of H<sub>2</sub>DCFDA and Amplex UltraRed is irreversible. Accordingly, accumulation of the oxidized dye results in a continuous increase in fluorescence emission. For H<sub>2</sub>DCFDA it was monitored with a fluorescence spectrophotometer (Hitachi F-7000) at 495 nm excitation and 525 nm emission wavelengths, and for Amplex UltraRed a multimode spectrophotometer (flx-Xenius XM, SAFAS Monaco) with 555 nm excitation and 581 nm emission wavelengths was used.</p>
</sec>
<sec>
<title>Body Temperature Measurements</title>
<p>The core body temperature of mice was determined with a rectal probe (MLT451) and a temperature controller (TC1000, ADInstruments) on three consecutive days. The first day served to adapt the mice to the procedure; the temperatures measured on the second and third day were averaged for each mouse.</p>
</sec>
<sec>
<title>Statistics</title>
<p>Throughout the manuscript, data are presented as mean ± standard deviation. For each diagram it is indicated whether the number of experiments (<italic>n</italic>) equals the number of cells analyzed (optical imaging) or the number of mice studied (biochemical assays, tissue samples). Significance of the differences observed was determined by unpaired two tailed student’s <italic>t</italic>-test. Genotype-related differences are marked by asterisks (<sup>∗∗∗</sup><italic>p</italic> &lt; 0.001, <sup>∗∗</sup><italic>p</italic> &lt; 0.01, <sup>∗</sup><italic>p</italic> &lt; 0.05) and genotype-matched differences among cell compartments are identified by crosshatches (<sup>###</sup><italic>p</italic> &lt; 0.001, <sup>##</sup><italic>p</italic> &lt; 0.01, <sup>#</sup><italic>p</italic> &lt; 0.05). In the case of normalized data, a one-sample <italic>t</italic>-test served to compare the observed changes to control conditions (defined as unity, i.e., 1.0 or 100%) (<xref ref-type="bibr" rid="B4">Bailey, 1992</xref>).</p>
</sec>
</sec>
<sec>
<title>Results</title>
<sec>
<title>Redox Balance in Mitochondrial Matrix and Cytosol</title>
<p>Our previous analyses revealed a cytosolic redox-imbalance in <italic>Mecp2<sup>-/y</sup></italic> hippocampus (<xref ref-type="bibr" rid="B30">Großer et al., 2012</xref>). To compare in detail the redox conditions in mitochondria and cytosol of <italic>Mecp2<sup>-/y</sup></italic> neurons in organotypic hippocampal slice cultures, we analyzed the resting-baseline (steady-state) redox conditions in both cell compartments, and recorded also their dynamic responses to various acute redox-stimuli. For these tasks, we used our recently established viral constructs. They express roGFP1 under the control of the synapsin 1 promoter, mediating a neuron specific expression, and proper subcellular targeting to either cytosol (cyto-roGFP1) or mitochondrial matrix (mito-roGFP1) (<xref ref-type="bibr" rid="B10">Can et al., 2017</xref>). RoGFP1 enables quantitative analyses of subcellular redox conditions, but this requires detailed response calibrations for each cell-compartment. Therefore, with saturating doses of H<sub>2</sub>O<sub>2</sub> (5 mM) and DTT (10 mM) we defined those ratiometric values which correspond to full roGFP1 oxidation and reduction, respectively (<xref ref-type="fig" rid="F1">Figure 1A</xref>). H<sub>2</sub>O<sub>2</sub> (7 min) increased the mito-roGFP1 ratio to 1.52 ± 0.16, and DTT decreased it to 0.68 ± 0.02 (<italic>n</italic> = 12, <xref ref-type="fig" rid="F1">Figure 1B</xref>). As cyto-roGFP1 responded more promptly, the redox-stimulants were applied for 5 min only, but very similar calibration values were obtained as in mitochondria (<italic>n</italic> = 20; <xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Reduction-oxidation sensitive green fluorescent protein 1 (roGFP1) response calibration reveals genotypic and compartmental redox differences at baseline resting conditions. <bold>(A)</bold> Dynamic response of cyto-roGFP1 to saturating oxidation and reduction, as recorded from a WT slice culture. <bold>(B)</bold> The box plot summarizes the response ranges of mito-roGFP1 and cyto-roGFP1 determined during the calibration experiments. The bottom of each box represents the fully reduced state evoked by 10 mM DTT, the ceiling indicates the fully oxidized level induced by 5 mM H<sub>2</sub>O<sub>2</sub>. Error bars in this and all other figures are standard deviations; the number of cells analyzed is reported for each bar. The similarity of the determined response ranges confirms that roGFP reliably functions in both, cytosol and mitochondrial matrix. <bold>(C)</bold> OxD<sub>roGFP1</sub> confirms more oxidized baseline conditions in the cytosol of <italic>Mecp2<sup>-/y</sup></italic> hippocampal neurons than in WT neurons. Mitochondrial redox baselines did not differ among genotypes. Statistically significant differences between WT and <italic>Mecp2<sup>-/y</sup></italic> neurons are indicated by asterisks (<sup>∗∗∗</sup><italic>p</italic> &lt; 0.001). Genotype-matched differences among mitochondria and cytosol are indicated by crosshatches (<sup>###</sup>p &lt; 0.001). Pairwise comparisons were run as unpaired two-tailed <italic>t</italic>-tests; the number of cells studied is included in each bar. <bold>(D)</bold> These genotypic and compartmental redox differences are also evident from the calculated roGFP1 reduction potentials (E<sub>roGFP1</sub>; <sup>##</sup><italic>p</italic> &lt; 0.01).</p>
</caption>
<graphic xlink:href="fphys-10-00479-g001"></graphic>
</fig>
<p>Based on these calibrations, the relative degrees of roGFP1 oxidation (OxD<sub>roGFP1</sub>) and E<sub>roGFP1</sub> were calculated for steady-state resting baseline conditions. To define genotype-related differences, the respective cell compartments were compared among WT and <italic>Mecp2<sup>-/y</sup></italic> slices. Furthermore, to identify subcellular, i.e., compartment-specific differences in a given genotype, cytosol and mitochondrial matrix were compared to each other. This revealed that in WT neurons, mitochondrial matrix was more oxidized than their cytosol. Yet, mitochondrial redox baselines did not differ among WT and <italic>Mecp2<sup>-/y</sup></italic> slices. In contrast, cytosolic redox balance was more oxidized in <italic>Mecp2<sup>-/y</sup></italic> than in WT neurons (<xref ref-type="fig" rid="F1">Figure 1C</xref>). As a result, the cytosol of <italic>Mecp2<sup>-/y</sup></italic> neurons was even more oxidized than their mitochondria. These compartmental and genotypic differences are also reflected by the E<sub>roGFP1</sub> (<xref ref-type="fig" rid="F1">Figure 1D</xref>).</p>
<p>Next, we assessed the dynamic redox responses of both cell compartments to defined challenges. As irregular respiration with intermittent hypoxia is a hallmark of RTT, the effect of O<sub>2</sub> shortage was determined. O<sub>2</sub> withdrawal (N<sub>2</sub>/CO<sub>2</sub>-aerated ACSF, 10 min), evoked a reducing shift in roGFP1 ratio, which was more intense in <italic>Mecp2<sup>-/y</sup></italic> mitochondria and <italic>Mecp2<sup>-/y</sup></italic> cytosol than in the WT compartments (<xref ref-type="fig" rid="F2">Figure 2A,E,F</xref>). Oxidant challenge was induced by low-dose H<sub>2</sub>O<sub>2</sub> or by inhibition of the scavenging enzyme SOD1 (Cu/Zn SOD). H<sub>2</sub>O<sub>2</sub> (200 μM, 3–5 min) elicited an oxidizing shift in roGFP1 ratio, which was more pronounced in <italic>Mecp2<sup>-/y</sup></italic> than in WT mitochondria, but did not differ among <italic>Mecp2<sup>-/y</sup></italic>, and WT cytosol (<xref ref-type="fig" rid="F2">Figure 2B,E,F</xref>). Blocking SOD1 by DEDTC (<xref ref-type="bibr" rid="B34">Iqbal and Whitney, 1991</xref>; <xref ref-type="bibr" rid="B24">Dumay et al., 2006</xref>) (5 mM, 5 min) induced an oxidation of roGFP1, which was consistently more pronounced in WT mitochondria and cytosol than in the respective <italic>Mecp2<sup>-/y</sup></italic> compartments (<xref ref-type="fig" rid="F2">Figure 2C,E,F</xref>). Mitochondrial impairment was mimicked by the CIII-blocker AMC (20 μM, 10 min), and it evoked a slow oxidizing shift, which was more intense in <italic>Mecp2<sup>-/y</sup></italic> mitochondria and cytosol as compared to the WT compartments (<xref ref-type="fig" rid="F2">Figure 2D–F</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Acute redox challenge uncovers a more fragile redox homeostasis in mitochondrial matrix and cytosol of <italic>Mecp2<sup>-/y</sup></italic> hippocampal neurons. <bold>(A)</bold> As revealed by the imaging of subcellular redox dynamics, O<sub>2</sub> withdrawal evoked a reducing shift in the cytosolic roGFP1 fluorescence ratio, which was more intense in <italic>Mecp2<sup>-/y</sup></italic> neurons. Time scaling also applies to the following traces. <bold>(B)</bold> Low-dose H<sub>2</sub>O<sub>2</sub> induced a more pronounced oxidation in <italic>Mecp2<sup>-/y</sup></italic> mitochondria. <bold>(C)</bold> The cytosol of <italic>Mecp2<sup>-/y</sup></italic> neurons responded less intensely to DEDTC, a blocker of SOD1. <bold>(D)</bold> Block of CIII by AMC elicited a more pronounced oxidation in <italic>Mecp2<sup>-/y</sup></italic> mitochondria. <bold>(E)</bold> Summary of the redox alterations in mitochondrial matrix. Plotted are changes in mito-roGFP1 ratio and in the mito-roGFP1 reduction potential. Asterisks indicate statistically significant differences as compared to WT in unpaired two-tailed <italic>t</italic>-tests (<sup>∗∗∗</sup><italic>p</italic> &lt; 0.001, <sup>∗∗</sup><italic>p</italic> &lt; 0.01, <sup>∗</sup><italic>p</italic> &lt; 0.05). The number of cells studied is reported for each bar. <bold>(F)</bold> Summarized redox responses of the cytosolic compartment (cyto-roGFP1).</p>
</caption>
<graphic xlink:href="fphys-10-00479-g002"></graphic>
</fig>
</sec>
<sec>
<title>Mitochondrial Mass and Expression Levels of Respiratory Complexes</title>
<p>An increased cellular density of mitochondria may be a potential cause of the oxidative burden in RTT. Therefore, we asked whether mitochondrial mass differs in WT and <italic>Mecp2<sup>-/y</sup></italic> mice. As mitochondrial marker we chose VDAC3, an integral membrane protein of the outer mitochondrial membrane; the cytosolic protein GAPDH served as loading control. Clear cellular lysates of hippocampus, cortex and heart (<italic>n</italic> = 5 each genotype) were separated by SDS-PAGE, and both proteins detected in the same sample by Western blot analysis (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Normalizing the expression of VDAC3 to GAPDH, did not reveal any differences in mitochondrial mass of adult <italic>Mecp2<sup>-/y</sup></italic> hippocampus or cortex as compared to WT. Only a trend toward increased mitochondrial mass was evident in <italic>Mecp2<sup>-/y</sup></italic> heart, which did, however, not reach the level of significance (<italic>p</italic> = 0.101; <xref ref-type="fig" rid="F3">Figure 3B</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Mitochondrial mass is not altered in <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex. <bold>(A)</bold> In Western blot analyses, VDAC3 served as mitochondrial marker. Its expression was referred to GAPDH, and tissue lysates of hippocampus, cortex, and heart were compared among WT and <italic>Mecp2<sup>-/y</sup></italic> siblings. Dashed line indicates the membrane cut after protein blotting. <bold>(B)</bold> In densitometric analyzes genotypic differences for hippocampus and cortex were not found. Mitochondrial mass tended to be higher though in <italic>Mecp2<sup>-/y</sup></italic> heart (<italic>n</italic> = 5 mice each). Plotted VDAC3/GAPDH ratios are normalized to WT conditions (defined as unity, see dashed line), statistical significance was assessed by one-sample <italic>t</italic>-tests.</p>
</caption>
<graphic xlink:href="fphys-10-00479-g003"></graphic>
</fig>
<p>As a reduced enzymatic activity of key mitochondrial functions is evident in RTT (<xref ref-type="bibr" rid="B13">Coker and Melnyk, 1991</xref>; <xref ref-type="bibr" rid="B38">Kriaucionis et al., 2006</xref>; <xref ref-type="bibr" rid="B28">Gibson et al., 2010</xref>; <xref ref-type="bibr" rid="B29">Gold et al., 2014</xref>; <xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>; <xref ref-type="bibr" rid="B64">Valenti et al., 2017</xref>), we analyzed steady state levels of constituents of the mitochondrial respiratory chain. Tissue lysates were separated by SDS-PAGE and protein levels of core constituents of the respiratory chain were analyzed by Western blotting (<xref ref-type="fig" rid="F4">Figure 4A</xref>). All complexes were detectable in the WT and <italic>Mecp2<sup>-/y</sup></italic> samples, but normalization to GAPDH content did not reveal any genotypic differences in the protein levels of CII, CIII, and CIV (<xref ref-type="fig" rid="F4">Figure 4B</xref>). In <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex, however, CI protein levels (NDUFB8) were slightly lower than in WT. Furthermore, ATP-synthase (CV, ATP5B) was slightly less expressed in <italic>Mecp2<sup>-/y</sup></italic> cortex (<xref ref-type="fig" rid="F4">Figure 4B</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Protein expression levels of NDUFB8 and ATP5B differ only slightly between <italic>Mecp2<sup>-/y</sup></italic> and WT mice. <bold>(A)</bold> Protein lysates were separated by SDS gel electrophoresis and analyzed by Western blotting, using antibodies specific against NDUFB8 (CI), SDHA (CII), Rieske (CIII), COX5A (CIV), ATP5B (CV), and GAPDH. Dashed lines indicate the membrane cut after protein blotting. The displayed blots of CII and CIII are from the same experiment and therefore share a common loading control; this also applies to CV and CI. <bold>(B)</bold> Expression levels of the proteins of interest were quantified by densitometry, normalized to GAPDH within the same tissue sample and then referred to the WT samples (defined as unity, see dashed line). The number of samples (mice) analyzed is reported; asterisks mark statistically significant differences as compared to WT in one sample <italic>t</italic>-tests (<sup>∗</sup><italic>p</italic> &lt; 0.05).</p>
</caption>
<graphic xlink:href="fphys-10-00479-g004"></graphic>
</fig>
</sec>
<sec>
<title>Structure of Mitochondrial Respiratory Chain Complexes</title>
<p>Structural changes of the mitochondrial respiratory chain may provoke the generation of ROS (<xref ref-type="bibr" rid="B12">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="B66">Vukotic et al., 2012</xref>). As roGFP1 imaging revealed exaggerated redox shifts of <italic>Mecp2<sup>-/y</sup></italic> mitochondria in response to hypoxia and AMC, we screened for potential structural changes of the mitochondrial respiratory chain. We isolated mitochondria from hippocampus, cortex, and heart by differential centrifugation of tissue lysates (<xref ref-type="bibr" rid="B2">Argan et al., 1983</xref>; <xref ref-type="bibr" rid="B23">Dudek et al., 2016</xref>) and solubilized the isolated mitochondria in the mild detergent digitonin to preserve the supercomplex association. Solubilized protein complexes were then separated by native gel electrophoresis (BN-PAGE) and detected using antibodies against the core component of the complexes. CI was exclusively integrated in supercomplexes and the CI + CIII complex, which was visualized using antibodies against the CI subunit NDUFB8 in the high molecular range of the native gel. CIII and CIV were detected clearly in supercomplexes but were also present as smaller complexes (<xref ref-type="fig" rid="F5">Figure 5A</xref>). ATPase was found in two complexes representing the monomeric V<sub>M</sub> and the dimeric form V<sub>D</sub>. Obvious differences in the supercomplex-assembly among WT and <italic>Mecp2<sup>-/y</sup></italic> tissues were not identified.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Pathological remodeling of the respiratory chain supercomplexes in mitochondria of <italic>Mecp2<sup>-/y</sup></italic> mice is not evident. <bold>(A)</bold> Isolated mitochondria were solubilized in digitonin, separated by native gel electrophoresis (BN-PAGE), and respiratory chain complexes were analyzed by Western blotting. Due to limited space, <italic>Mecp2<sup>-/y</sup></italic> tissue is denoted here as “<italic>-/y”</italic>. <bold>(B)</bold> Respiratory chain complexes were separated by BN-PAGE and stained for enzymatic activity of CI, CIV, and CV. Marked alterations for the respective respiratory complexes were not found. The section of the gel flanked by the dashed lines was analyzed in more detail in panel <bold>C</bold>. <bold>(C)</bold> Quantitative analysis of CI activity staining by densitometry does not reveal marked genotypic differences among WT and <italic>Mecp2<sup>-/y</sup></italic> hippocampus. Dashed line indicates WT conditions, the number of samples (mice) analyzed is indicated (<sup>∗</sup><italic>p</italic> &gt; 0.05, one sample <italic>t</italic>-test).</p>
</caption>
<graphic xlink:href="fphys-10-00479-g005"></graphic>
</fig>
<p>Therefore, we next analyzed the activity of the respiratory chain. The complexes were separated by BN-PAGE and subsequently their enzymatic activity visualized by in-gel activity staining. This method allows a direct correlation of their enzymatic activity with their position on the BN-PAGE gel. Specific staining for CI, CIV, and ATP synthase activity corresponded well with their positions in Western blot analyses, confirming specificity of the chosen antibodies (<xref ref-type="fig" rid="F4">Figure 4</xref>, <xref ref-type="fig" rid="F5">5A</xref>). Activity staining showed most intense signals for heart, which also corresponds well to stronger signals in the Western blot approach (<xref ref-type="fig" rid="F5">Figure 5B</xref>). Also for brain, prominent CI signals were obtained consistently. As CI showed a well distinguishable pattern, the individual bands (750, 850, 900, and 950 kDa) were specifically analyzed by densitometry and normalized to the respective WT pattern; pronounced differences were, however, not found (<xref ref-type="fig" rid="F5">Figure 5C</xref>). Hence, despite detailed analyses of brain and heart tissues, the in-gel activities of CI, CIV, and CV did not markedly differ among WT and <italic>Mecp2<sup>-/y</sup></italic> mice.</p>
</sec>
<sec>
<title>Mitochondrial O<sub>2</sub> Consumption Rates</title>
<p>Potential defects of the energy transmission in between complexes of the respiratory chain can be assessed only by quantifying the consumption of molecular oxygen. Isolated mitochondria from hippocampus, cortex and heart of WT, and <italic>Mecp2<sup>-/y</sup></italic> mice therefore underwent real-time respirometry (<xref ref-type="fig" rid="F6">Figure 6A</xref>). Mitochondrial suspensions were supplied with CI substrates (2 mM malate, 10 mM pyruvate) to define the O<sub>2</sub> consumption rate of basal respiration. Adding ADP (12 mM) then markedly increased O<sub>2</sub> consumption (state 3 respiration) to a similar extent in WT and <italic>Mecp2<sup>-/y</sup></italic> samples (<xref ref-type="fig" rid="F6">Figure 6A</xref>). Subsequent inhibition of ATP synthase (1.5 μM oligomycin) largely diminished O<sub>2</sub> consumption in all samples, but did not reveal any genotype-related differences. FCCP application (4 μM) then evoked the maximal uncoupler-stimulated respiratory state, again, without revealing genotypic differences. Finally, mitochondrial respiration was blocked by AMC (4 μM) plus rotenone (2 μM), which almost completely abolished O<sub>2</sub> consumption. The remaining fraction of residual O<sub>2</sub> consumption did not differ either among <italic>Mecp2<sup>-/y</sup></italic> and WT samples.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Intensified O<sub>2</sub> consumption by mitochondria of <italic>Mecp2<sup>-/y</sup></italic> brain in the presence of CII substrates. <bold>(A)</bold> O<sub>2</sub> consumption rates of isolated mitochondria were measured at basal conditions in the presence of CI substrates. Subsequent measurements were performed after administration of ADP, the uncoupler FCCP and AMC plus rotenone. Neither basal respiration nor the other respiration states differed among WT and <italic>Mecp2<sup>-/y</sup></italic> tissues. The number of samples (mice) analyzed is shown in the legend of each plot. <bold>(B)</bold> In the presence of ADP and the CII substrate succinate, O<sub>2</sub> consumption was increased in <italic>Mecp2<sup>-/y</sup></italic> hippocampal and cortical mitochondria as compared to WT (<sup>∗∗∗</sup><italic>p</italic> &lt; 0.001, unpaired two-tailed <italic>t</italic>-test). In heart, no changes were found. <bold>(C)</bold> Rotenone abolished the genotypic differences, suggesting that reverse electron flow from succinate into CI contributes to the increased O<sub>2</sub> consumption of mitochondria from <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex. <bold>(D)</bold> The rotenone effect is especially clear, when the mitochondrial O<sub>2</sub> consumption rates of <italic>Mecp2<sup>-/y</sup></italic> samples are normalized to the respective WT conditions (<sup>∗</sup><italic>p</italic> &lt; 0.05, <sup>∗∗</sup><italic>p</italic> &lt; 0.01, <sup>∗∗∗</sup><italic>p</italic> &lt; 0.001; one sample <italic>t</italic>-tests).</p>
</caption>
<graphic xlink:href="fphys-10-00479-g006"></graphic>
</fig>
<p>Recently, a dysfunction of CII was reported for female Rett mice (<xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>). Therefore, we quantified mitochondrial O<sub>2</sub> consumption also in the presence of the CII substrate succinate (4 mM). Indeed, respiration after addition of ADP (10 mM) was increased in <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex as compared to WT samples (<xref ref-type="fig" rid="F6">Figure 6B</xref>). In heart, this genotypic difference was not evident. As reverse electron flux through complex I is one of the major mechanisms of mitochondrial ROS production (<xref ref-type="bibr" rid="B42">McLennan and Degli Esposti, 2000</xref>; <xref ref-type="bibr" rid="B22">Dröse, 2013</xref>), we included rotenone (10 μM) into the assay buffer. Under these conditions, which prevent a reverse electron transport from succinate, the increased O<sub>2</sub> consumption rates in <italic>Mecp2<sup>-/y</sup></italic> cortex and hippocampus were no longer evident (<xref ref-type="fig" rid="F6">Figure 6C</xref>). This is in particular evident, when the normalized respiration rates (<italic>Mecp2<sup>-/y</sup></italic> referred to WT) are plotted (<xref ref-type="fig" rid="F6">Figure 6D</xref>).</p>
</sec>
<sec>
<title>Mitochondrial ROS Production</title>
<p>To assess whether the altered mitochondrial activities in <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex may give rise to an increased oxidative burden, we monitored the ROS generation of mitochondrial suspensions in a spectrofluorometric assay with the oxidation-sensitive dyes H<sub>2</sub>DCFDA and Amplex UltraRed. The extent and time course of dye oxidation depend on the amount of ROS generated, and were compared for isolated mitochondria from adult WT and <italic>Mecp2<sup>-/y</sup></italic> brains. As both dyes may be prone to photo- and auto-oxidation, we also analyzed control cuvettes containing buffer plus dye but no mitochondria. Monitoring H<sub>2</sub>DCFDA fluorescence over 20 minutes showed a pronounced oxidation only in the native mitochondria-containing samples and a more intense ROS formation by <italic>Mecp2<sup>-/y</sup></italic> mitochondria (<xref ref-type="fig" rid="F7">Figure 7A</xref>). In contrast, in denaturing buffer (Triton X-100), we did not observe a marked oxidation of H<sub>2</sub>DCFDA nor any genotypic differences, confirming their dependence on native mitochondria with fully functional respiratory complexes as well as intact mitochondrial membranes (<xref ref-type="fig" rid="F7">Figure 7B</xref>). For verification, we ran this assay also for native mitochondria in the presence of CI plus CII substrates (2 mM malate, 10 mM pyruvate, 4 mM succinate), and again observed a more intense ROS formation in <italic>Mecp2<sup>-/y</sup></italic> than in WT hippocampal and cortical mitochondria (<xref ref-type="fig" rid="F7">Figure 7C</xref>). For further confirmation, mitochondrial ROS formation was then rated also with the more reliable reagent Amplex UltraRed. This again verified a more intense ROS generation in native, energized mitochondria from <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex (<xref ref-type="fig" rid="F7">Figure 7C</xref>).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Increased ROS release from mitochondria of <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex. <bold>(A)</bold> ROS generation was quantified in mitochondrial suspensions under native conditions (assay buffer without substrates) using the oxidation-sensitive dye H<sub>2</sub>DCFDA. Genotypic comparison reveals an increased ROS formation by mitochondria from <italic>Mecp2<sup>-/y</sup></italic> hippocampus. The control cuvettes (Ctl) contain buffer plus dye only and report the extent of photo- and autoxidation of H<sub>2</sub>DCFDA during the course of this assay. <bold>(B)</bold> In contrast, under denaturing conditions, neither a pronounced oxidation of H<sub>2</sub>DCFDA nor a genotypic difference among WT and <italic>Mecp2<sup>-/y</sup></italic> hippocampus was observed. This confirms that it is indeed the native mitochondria, which mediate the marked oxidation of H<sub>2</sub>DCFDA in this cuvette assay. <bold>(C)</bold> Also with the substrates malate, pyruvate, and succinate included into the assay buffer, mitochondria from <italic>Mecp2<sup>-/y</sup></italic> hippocampus (HC) and cortex (CTX) released higher amounts of ROS than WT mitochondria (dashed line). This was confirmed unequivocally also with the more reliable reagent Amplex UltraRed. For comparison of the different conditions tested, the normalized fluorescence ratios are plotted, by referring <italic>Mecp2<sup>-/y</sup></italic> responses to the respective WT conditions. The number of samples (mice) analyzed is reported; asterisks mark statistically significant differences as compared to WT (one sample <italic>t</italic>-tests; <sup>∗</sup><italic>p</italic> &lt; 0.05, <sup>∗∗∗</sup><italic>p</italic> &lt; 0.001).</p>
</caption>
<graphic xlink:href="fphys-10-00479-g007"></graphic>
</fig>
</sec>
<sec>
<title>Body Temperature Measurements</title>
<p>Intensified mitochondrial metabolism may result in an increased body temperature, as part of the energy resting in the proton gradient may be converted into heat by regulated uncoupling (<xref ref-type="bibr" rid="B47">Nicholls and Locke, 1984</xref>; <xref ref-type="bibr" rid="B52">Ricquier and Bouillaud, 2000</xref>). Therefore, we measured the core body temperatures of WT and <italic>Mecp2<sup>-/y</sup></italic> mice (∼PD50). On average, WT males had a body temperature of 37.4 ± 0.6°C (<italic>n</italic> = 11), whereas it was lower in <italic>Mecp2<sup>-/y</sup></italic> males (35.7 ± 1.1°C, <italic>n</italic> = 12). Hence, a direct effect of the detected mitochondrial alterations on body temperature can be excluded, and the lower temperature of <italic>Mecp2<sup>-/y</sup></italic> mice is likely a consequence of their markedly reduced body weights (WT 21.5 ± 1.2 g; <italic>Mecp2<sup>-/y</sup></italic> 12.4 ± 2.1 g).</p>
</sec>
</sec>
<sec>
<title>Discussion</title>
<p>In the present study we quantified subcellular redox changes in hippocampal neurons, and assessed molecular changes of the individual respiratory complexes, their enzymatic activities, and their O<sub>2</sub> consumption rates in brain and heart tissue. For these analyzes it was essential to ensure a complete lack of MeCP2 in each single cell being studied. Therefore, the heterozygous condition in female <italic>Mecp2<sup>+/-</sup></italic> mice – which would have resulted in a mixed population of cells expressing and lacking MeCP2 – was circumvented by running all experiments on tissue isolated from male mice. Of course, RTT affects mostly females, but here disease mechanisms were studied on the (sub)cellular level. For a later <italic>in vivo</italic> assessment of redox-balance based therapies, it would of course be essential to include also female mice in the experiments, as only they truthfully represent the clinically relevant heterozygous condition.</p>
<sec>
<title>Redox Conditions in Mitochondrial Matrix and Cytosol</title>
<p>Subcellular redox conditions were imaged using the genetically encoded roGFP1 sensor (<xref ref-type="bibr" rid="B21">Dooley et al., 2004</xref>; <xref ref-type="bibr" rid="B33">Hanson et al., 2004</xref>). Whereas our previous studies still relied on lipofection (<xref ref-type="bibr" rid="B30">Großer et al., 2012</xref>; <xref ref-type="bibr" rid="B5">Bebensee et al., 2017</xref>), we now took advantage of our recently developed viral constructs (<xref ref-type="bibr" rid="B10">Can et al., 2017</xref>), to assure a highly neuron-specific expression of roGFP1. With this marked improvement, we specifically addressed redox balance in neurons of <italic>Mecp2<sup>-/y</sup></italic> hippocampus, and obtained for the very first time a functional readout of redox conditions in living MeCP2-deficient cells at subcellular resolution. Clear compartmental differences became apparent. In WT neurons, mitochondria were more oxidized than the cytosol, which corresponds to smooth muscle (<xref ref-type="bibr" rid="B70">Waypa et al., 2010</xref>), and our findings in excitatory hippocampal neurons of adult redox-indicator mice (<xref ref-type="bibr" rid="B67">Wagener et al., 2016</xref>). Furthermore, in <italic>Mecp2<sup>-/y</sup></italic> neurons, the cytosol was more oxidized than in WT, and it was even more oxidized than the mitochondrial matrix of <italic>Mecp2<sup>-/y</sup></italic> neurons. In RTT, it therefore seems to be especially the cytosolic compartment, which is affected by an impaired and more oxidized redox balance.</p>
<p>In mitochondrial matrix, genotypic differences in redox resting baseline levels were not obvious. Nevertheless, mitochondria may challenge cytosolic redox balance by releasing oxidants. Superoxide is generated especially at CI and CIII (<xref ref-type="bibr" rid="B8">Boveris and Chance, 1973</xref>; <xref ref-type="bibr" rid="B65">Votyakova and Reynolds, 2001</xref>; <xref ref-type="bibr" rid="B9">Brand, 2010</xref>) and it accumulates not only in the matrix but also in the intermembrane space (<xref ref-type="bibr" rid="B9">Brand, 2010</xref>), from where it then may reach the cytosol. Indeed, earlier studies on isolated full brain and cerebellar mitochondria demonstrated by homovanillic acid/horseradish peroxidase-based spectrophotometric assays that mitochondria of female Rett mice generate larger amounts of H<sub>2</sub>O<sub>2</sub> than those of WT mice (<xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>; <xref ref-type="bibr" rid="B64">Valenti et al., 2017</xref>).</p>
<p>In line with these reports we observed a more intense oxidation of H<sub>2</sub>DCFDA and Amplex UltraRed by native <italic>Mecp2<sup>-/y</sup></italic> hippocampal and cortical mitochondria. Despite being a common approach, H<sub>2</sub>DCFDA-assays need to be interpreted carefully, especially when applied in complex systems such as isolated tissues or intact cells. In contrast to Amplex UltraRed, H<sub>2</sub>DCFDA is not specific for H<sub>2</sub>O<sub>2</sub> but responds also to hydroxyl radicals, peroxynitrite, and carbonate anion radicals. Furthermore, it may be oxidized by heme proteins or via Fenton chemistry by transition metals, and the enzymatic deacetylation of H<sub>2</sub>DCFDA as well as the oxidation of H<sub>2</sub>DCF may intrinsically generate ROS (<xref ref-type="bibr" rid="B55">Rota et al., 1999</xref>; <xref ref-type="bibr" rid="B7">Bonini et al., 2006</xref>; <xref ref-type="bibr" rid="B69">Wardman, 2007</xref>; <xref ref-type="bibr" rid="B36">Kalyanaraman et al., 2012</xref>). Therefore, we conducted the H<sub>2</sub>DCFDA assay in the simplified preparation of isolated mitochondria under native as well as denatured conditions and included respective controls.</p>
<p>In mitochondria-free buffers, an only slight oxidation of H<sub>2</sub>DCFDA occurred, ruling out transition metal contaminations of assay solutions or pronounced autoxidation. In denatured mitochondria (Triton-X100) a partial oxidation of H<sub>2</sub>DCFDA but no genotypic differences were seen. Therefore, some transition metal- or heme protein-mediated oxidation of H<sub>2</sub>DCFDA may have occurred in a genotype-independent manner. As most intense H<sub>2</sub>DCFDA oxidation and clear genotypic differences were evident in native mitochondria only, they can be assumed to depend largely on an intact inner mitochondrial membrane, a functional respiratory chain and mitochondrial membrane potential, and hence the ROS-formation inherent to mitochondrial (patho)physiology. Quantification or identification of the very oxidants involved is of course not possible with this assay for the above mentioned problems; also the obtained oxidation rates might be overestimated in view of the autocatalytic nature of the fluorescence dye used. For unequivocal confirmation, we therefore ran the Amplex UltradRed assay which specifically detects H<sub>2</sub>O<sub>2</sub> (<xref ref-type="bibr" rid="B76">Zhou et al., 1997</xref>; <xref ref-type="bibr" rid="B37">Komary et al., 2010</xref>), and verified a more intense H<sub>2</sub>O<sub>2</sub> release for native <italic>Mecp2<sup>-/y</sup></italic> hippocampal and cortical mitochondria. In view of genotype-related differences, it therefore can be concluded that isolated native <italic>Mecp2<sup>-/y</sup></italic> hippocampal and cortical mitochondria mediate a higher oxidative burden than WT mitochondria, which also includes the release of intensified amounts of ROS.</p>
<p>In addition to the differing steady-state redox baselines, acute redox challenges confirmed also a less stable redox homeostasis in <italic>Mecp2<sup>-/y</sup></italic> cytosol and mitochondria. Blocking of CIII elicited more intense oxidizing responses in <italic>Mecp2<sup>-/y</sup></italic> cytosol and mitochondria. Upon O<sub>2</sub> withdrawal, both compartments showed more pronounced reducing shifts than those in WT neurons. In contrast, inhibiting SOD1 evoked less intense oxidations in <italic>Mecp2<sup>-/y</sup></italic> cytosol and mitochondria than in WTs, which matches the dampened SOD1 activity found in RTT patient blood samples (<xref ref-type="bibr" rid="B60">Sierra et al., 2001</xref>). The cerebral redox-imbalance in RTT is, however, not limited to neurons. Just recently, we found the cytosol of <italic>Mecp2<sup>-/y</sup></italic> hippocampal astrocytes to be more oxidized than in WTs (<xref ref-type="bibr" rid="B5">Bebensee et al., 2017</xref>).</p>
<p>The roGFP1 redox sensor contains exposed thiols, which adjust to ambient redox conditions. Therefore, it does not detect a particular oxidant, but rather reports general thiol redox balance, and it behaves as other cell-endogenous redox-sensitive proteins, which are controlled by redox-sensing thiols (<xref ref-type="bibr" rid="B33">Hanson et al., 2004</xref>; <xref ref-type="bibr" rid="B43">Meyer and Dick, 2010</xref>). Such redox regulation of protein function/activity was estimated to affect &gt;800 (human) proteins (<xref ref-type="bibr" rid="B71">Weerapana et al., 2010</xref>). Accordingly, the redox imbalance in cytosol and mitochondria of <italic>Mecp2<sup>-/y</sup></italic> hippocampus may tremendously disturb protein function via either too reducing or too oxidizing conditions. This would already suffice to provoke neuronal dysfunction and distort neuronal network properties, long before oxidative tissue damage occurs.</p>
</sec>
<sec>
<title>Mitochondrial Mass and Protein Expression Levels</title>
<p>A crucial aspect, in which our mitochondrial assays differ from most earlier studies is that no sample pooling or full brain analyzes were performed. Instead, to detect subtle differences among <italic>Mecp2<sup>-/y</sup></italic> and WT mice, we analyzed defined brain samples of individual mice. Also, we included heart tissue to assess mitochondrial function in another organ as well. Nevertheless, it is important to recall that even isolated from specified tissues of individual mice, mitochondrial suspensions derive from mixed cell populations, i.e., various neurons and glial cells in the case of brain samples.</p>
<p>Our Western blot analyses on hippocampus and cortex did not indicate any changes in mitochondrial mass. This is in line with MeCP2-deficient mouse fibroblasts and <italic>MECP2</italic> mutant human embryonic stem cells differentiated into neurons (<xref ref-type="bibr" rid="B40">Li et al., 2013</xref>; <xref ref-type="bibr" rid="B59">Shulyakova et al., 2017</xref>). Yet, we saw a trend toward increased mitochondrial mass in <italic>Mecp2<sup>-/y</sup></italic> heart, and cell culture studies found higher mitochondrial contents in microglia (<xref ref-type="bibr" rid="B35">Jin et al., 2015</xref>) and hippocampal astrocytes of juvenile Rett mice (<xref ref-type="bibr" rid="B5">Bebensee et al., 2017</xref>). In part, an increased mitochondrial mass may serve to compensate the mitochondrial underperformance in RTT. However, this seems to be cell- and tissue-specific, and limited to certain developmental stages or experimental preparations. It certainly cannot explain in general the redox imbalance in RTT.</p>
<p>Rett mouse brains and patient-derived tissues present a heterogeneous spectrum of mitochondrial alterations (<xref ref-type="bibr" rid="B46">Müller and Can, 2014</xref>; <xref ref-type="bibr" rid="B63">Valenti et al., 2014</xref>; <xref ref-type="bibr" rid="B59">Shulyakova et al., 2017</xref>). Seemingly contradictory results arose especially from gene-arrays. An overall upregulation of the subunits of various respiratory complexes was found in blood (lymphomonocytes) of RTT patients (<xref ref-type="bibr" rid="B50">Pecorelli et al., 2013</xref>), whereas a genome-wide transcriptional repression, including various mitochondrial proteins, was evident in an embryonic stem cell model of RTT (<xref ref-type="bibr" rid="B40">Li et al., 2013</xref>). This emphasizes the importance of standardized procedures and the need of analyzing not only differential transcription, but also final protein levels. Fact is that despite potential candidate genes, details on actual changes in mitochondrial protein expression are still sparse. In late symptomatic male Rett mice, a downregulation of CI was seen in full brain mitochondria (<xref ref-type="bibr" rid="B38">Kriaucionis et al., 2006</xref>), and a lower expression of CIV was found in skeletal muscle (<xref ref-type="bibr" rid="B29">Gold et al., 2014</xref>). More recent whole brain studies on female MeCP2-308 mice did not reveal any obvious alterations of the individual mitochondrial complexes (<xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>; <xref ref-type="bibr" rid="B64">Valenti et al., 2017</xref>). Instead, alterations were region specific, affecting the striatum in which CI and CIII showed lowered protein expression levels (<xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>).</p>
<p>This regional specificity corroborates our results from symptomatic <italic>Mecp2<sup>-/y</sup></italic> mice. CI (NDUFB8) was slightly less expressed in <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex than in WT, and CV (ATP5B) was slightly less expressed in <italic>Mecp2<sup>-/y</sup></italic> cortex. Interesting in view of the CII-related intensified O<sub>2</sub> consumption in <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex may be the trend toward an increased CII expression (SDHA) in these areas. Evidence for a lowered expression of CIV, as reported for <italic>post mortem</italic> frontal cortex of patients (<xref ref-type="bibr" rid="B28">Gibson et al., 2010</xref>), was not found in our mouse samples. Interestingly, in heart tissue no genotypic differences in the expression of the respiratory complexes were detected.</p>
</sec>
<sec>
<title>Functionality and Stability of Respiratory Supercomplexes</title>
<p>The intensified mitochondrial ROS generation in Rett mice and the associated oxidative stress could aggravate mitochondrial dysfunction by destabilizing individual subunits of the supercomplex, abolishing facilitated electron channeling and releasing further ROS. However, steady state protein levels of the core components of the respiratory chain did not reveal noticeable changes. Neither were any obvious genotypic differences in the organization or enzymatic activity of mitochondrial supercomplexes detected in hippocampus, cortex and heart. Thus, a structural remodeling of the highly energy efficient supramolecular assemblies cannot be a cause for the limited mitochondrial performance in RTT.</p>
<p>This does not rule out, however, that the altered metabolic rate of isolated mitochondria may arise from a differential expression or altered enzymatic activities of some smaller regulatory subunits of these supercomplexes. Along this line, protein kinase A-dependent phosphorylation of CI (NDUFS4), which controls respiratory capacity and mitochondrial ROS formation, is decreased in the cerebellum of female Rett mice (<xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>). Also elevated expression of the adenine nucleotide transporter 1 (ANT1) was proposed to cause an enhanced basal H<sup>+</sup> leak of the inner mitochondrial membrane, followed by a compensatory increase of mitochondrial respiration (<xref ref-type="bibr" rid="B59">Shulyakova et al., 2017</xref>).</p>
<p>In-gel activity staining revealed no obvious genotype-specific defects in the enzymatic activities of CI, CIV, and CV. This suggests that at least in hippocampus, cortex and heart of <italic>Mecp2<sup>-/y</sup></italic> mice, enzymatic activities of mitochondrial complexes are mostly intact. In line with this is also the unaltered ATP content we detected in the hippocampus of symptomatic <italic>Mecp2<sup>-/y</sup></italic> mice (<xref ref-type="bibr" rid="B26">Fischer et al., 2009</xref>). Earlier studies on full brains mostly found reduced mitochondrial activities. Heterozygous female Rett mice (MeCP2-308) show lower CII and CV enzyme activities (<xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>), whereas in <italic>Mecp2<sup>+/-</sup></italic> mice CI, CII, and CV are less active (<xref ref-type="bibr" rid="B64">Valenti et al., 2017</xref>). In contrast, for <italic>Mecp2<sup>-/y</sup></italic> mice a reduced CIV activity and an enhanced CIII activity were reported (<xref ref-type="bibr" rid="B38">Kriaucionis et al., 2006</xref>). Also skeletal muscle analyses revealed dampened enzyme activities of CII, CIII, and CIV in male MeCP2-deficient mice (<xref ref-type="bibr" rid="B29">Gold et al., 2014</xref>). Similarly, in patient muscle, succinate cytochrome <italic>c</italic> reductase (CII–CIII) and CIV activities are diminished (<xref ref-type="bibr" rid="B13">Coker and Melnyk, 1991</xref>). Analyzing cardiac muscle, we did not detect any changes in the enzyme activities of the respiratory complexes.</p>
</sec>
<sec>
<title>Mitochondrial O<sub>2</sub> Consumption Rates</title>
<p>Quantifying mitochondrial O<sub>2</sub> consumption revealed no changes for <italic>Mecp2<sup>-/y</sup></italic> heart, but increased rates for <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex fueled by CII substrates. This genotypic difference vanished in the presence of rotenone, which suggests that reverse electron flow into CI may be a contributing factor. As CII is not integrated structurally into the respiratory chain supercomplexes, we did not expect to observe any corresponding structural differences in the native gel electrophoresis. Others determined the O<sub>2</sub> consumption rates of mitochondria from whole <italic>Mecp2<sup>-/y</sup></italic> brain with polarographic O<sub>2</sub> electrodes, and observed elevated rates for all respiration states (<xref ref-type="bibr" rid="B38">Kriaucionis et al., 2006</xref>). Also in <italic>Mecp2<sup>-/y</sup></italic> microglia the O<sub>2</sub> consumption is increased (<xref ref-type="bibr" rid="B35">Jin et al., 2015</xref>). In female Rett mice (MeCP2-308), increased respiratory rates were found in full brain-derived mitochondria fueled by complex II substrates (<xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>; <xref ref-type="bibr" rid="B64">Valenti et al., 2017</xref>), indicating that mitochondrial defects also extend to the milder heterozygous genotype. In contrast, <italic>MECP2</italic> mutant human neurons, derived from stem cells, showed a lower basal O<sub>2</sub> consumption, and reduced maximal respiration rate (<xref ref-type="bibr" rid="B40">Li et al., 2013</xref>), but these data were normalized to cell count and not to protein content.</p>
<p>As the observed reverse electron flow into CI may provoke maximal mitochondrial ROS production – especially with succinate as substrate (<xref ref-type="bibr" rid="B65">Votyakova and Reynolds, 2001</xref>) – this may well explain the more oxidized redox balance in <italic>Mecp2<sup>-/y</sup></italic> hippocampal neurons, and similar conditions can be expected for cortical neurons. Others report intensified H<sub>2</sub>O<sub>2</sub> formation by isolated brain mitochondria (<xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>; <xref ref-type="bibr" rid="B64">Valenti et al., 2017</xref>) and elevated oxidative stress markers in blood, muscle and brain of Rett mice (<xref ref-type="bibr" rid="B16">De Felice et al., 2014</xref>; <xref ref-type="bibr" rid="B29">Gold et al., 2014</xref>).</p>
<p>A potential impact of the detected redox- and metabolic alterations on mitochondrial morphology remains to be elucidated. Our current focus was on functional aspects; nevertheless, this structural/functional interaction may be of interest as the RTT–related alterations in mitochondrial function may not necessarily be accompanied by gross alterations in their morphology (<xref ref-type="bibr" rid="B38">Kriaucionis et al., 2006</xref>).</p>
</sec>
</sec>
<sec>
<title>Conclusion</title>
<p>Our study confirms by quantitative subcellular redox imaging that the redox imbalance in RTT affects neurons and involves their cytosol and mitochondria. Major changes in the expression and enzyme activity of the respiratory complexes were not found, and a dissociation of mitochondrial supercomplexes was ruled out. Accordingly, massive mitochondrial defects and/or marked dysfunction of entire respiratory complexes can be excluded, which matches the observation that a pronounced neurodegeneration does not occur in RTT (<xref ref-type="bibr" rid="B3">Armstrong et al., 1995</xref>). Instead, only moderate alterations in mitochondrial function and/or mitochondrial regulation are to be expected, which may result in an inefficient electron flow within the respiratory chain, but do not threaten cellular viability. In line with this concept, mitochondria from <italic>Mecp2<sup>-/y</sup></italic> hippocampus and cortex consumed more O<sub>2</sub>. This confirms the earlier proposed intensified mitochondrial respiration rates (<xref ref-type="bibr" rid="B38">Kriaucionis et al., 2006</xref>; <xref ref-type="bibr" rid="B30">Großer et al., 2012</xref>) and supports the concept that the mitochondrial underperformance in RTT may be considered an <italic>“energy wasting state”</italic> with increased O<sub>2</sub> consumption but lowered ATP production (<xref ref-type="bibr" rid="B35">Jin et al., 2015</xref>). In view of these changes and the increased mitochondria mediated oxidative stress and ROS formation detected by us and others (<xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>; <xref ref-type="bibr" rid="B64">Valenti et al., 2017</xref>), a causal chain appears more than likely. It spans from increased mitochondrial activity and O<sub>2</sub> consumption, over exaggerated mitochondrial ROS release and cytosolic/mitochondrial redox imbalance to disturbed neuronal network function and a facilitation of disease progression.</p>
<p>Interestingly, alterations in mitochondrial morphology and metabolism with closely associated oxidative stress have also been confirmed for autism-spectrum disorders, Down syndrome and fragile X syndrome, which suggests that these alterations may be common to a broad array of genetic disorders with are closely associated with intellectual disabilities [see: (<xref ref-type="bibr" rid="B54">Rossignol and Frye, 2012</xref>; <xref ref-type="bibr" rid="B63">Valenti et al., 2014</xref>)]. Hence, a chain of common disease mechanisms may have to be considered, which emphasizes the importance of clarifying the detailed interrelation of mitochondrial alterations, redox imbalance and symptom severity.</p>
<p>In human neuroblastoma cells, a direct causal link of MeCP2 availability and mitochondrial function was proven by MeCP2 knockdown, which resulted in a diminished cytochrome <italic>c</italic> oxidase activity (<xref ref-type="bibr" rid="B28">Gibson et al., 2010</xref>). Accordingly, a therapeutic targeting of mitochondria appears promising. Indeed treating female Rett mice with the serotonin receptor 7 agonist LP-211 or the bacterial protein CNF1 (cytotoxic necrotizing factor 1) improved mitochondrial function and dampened their ROS production (<xref ref-type="bibr" rid="B18">De Filippis et al., 2015</xref>; <xref ref-type="bibr" rid="B64">Valenti et al., 2017</xref>). Therefore, it will be crucial now to define in detail the exact time course of mitochondrial impairment as well as the particular brain areas affected by these alterations and the downstream redox-imbalance. Only then, it will be possible to assess and judge reliably the potential merits of mitochondria- and redox-directed treatments in RTT.</p>
</sec>
<sec>
<title>Ethics Statement</title>
<p>All experiments were in accordance with German regulations and authorized by the Office of Animal Welfare of the University Medical Center Göttingen as well as by the Lower Saxony State Office for Consumer Protection and Food Safety.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>KC planned and conducted the redox-imaging experiments, analyzed the data and generated the figures, and contributed to writing of the manuscript. CM, LR, and GG planned and conducted the biochemical mitochondria-analyzes, analyzed the data and generated the figures, and contributed to writing of the manuscript. PR supervised all mitochondrial analyzes and commented data and manuscript. SK designed and generated the viral expression vectors and commented data and manuscript. JD co-supervised and planned the biochemical analyzes, commented data and manuscript, and contributed to manuscript writing. MM planned and supervised the entire project, finalized the data analyzes and data presentations, and prepared the final version of the manuscript. All authors read and agreed to the final version of the manuscript.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This study was supported by the Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), the International Rett Syndrome Foundation (IRSF, research grant #2817), and the SFB1286. GG was supported by a fellowship of the Carl Friedrich Lehman-Haupt International Doctoral Program (Volkswagen Stiftung and Shota Rustaveli Science Foundation of Georgia). The publication costs of this article were covered by the Open Access Publishing Programme of the DFG.</p>
</fn>
</fn-group>
<ack>
<p>We are grateful to Belinda Kempkes for her expert technical assistance and to Prof. S. James Remington (Institute of Molecular Biology, University of Oregon, Eugene, OR, United States) for making available to us the plasmids expressing roGFP1 redox-sensitive proteins as well as their sequences.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amir</surname><given-names>R. E.</given-names></name><name><surname>Van Den Veyver</surname><given-names>I. B.</given-names></name><name><surname>Wan</surname><given-names>M.</given-names></name><name><surname>Tran</surname><given-names>C. Q.</given-names></name><name><surname>Francke</surname><given-names>U.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>1999</year>). <article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>23</volume>
<fpage>185</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1038/13810</pub-id>
<pub-id pub-id-type="pmid">10508514</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Argan</surname><given-names>C.</given-names></name><name><surname>Lusty</surname><given-names>C. J.</given-names></name><name><surname>Shore</surname><given-names>G. C.</given-names></name></person-group> (<year>1983</year>). <article-title>Membrane and cytosolic components affecting transport of the precursor for ornithine carbamyltransferase into mitochondria.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>258</volume>
<fpage>6667</fpage>–<lpage>6670</lpage>. <pub-id pub-id-type="pmid">6853495</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>D.</given-names></name><name><surname>Dunn</surname><given-names>J. K.</given-names></name><name><surname>Antalffy</surname><given-names>B.</given-names></name><name><surname>Trivedi</surname><given-names>R.</given-names></name></person-group> (<year>1995</year>). <article-title>Selective dendritic alterations in the cortex of Rett syndrome.</article-title>
<source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>54</volume>
<fpage>195</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1097/00005072-199503000-00006</pub-id><pub-id pub-id-type="pmid">7876888</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>N. T. J.</given-names></name></person-group> (ed.) (<year>1992</year>). <source/><italic>Statistical Methods in Biology.</italic>
<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>.</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bebensee</surname><given-names>D. F.</given-names></name><name><surname>Can</surname><given-names>K.</given-names></name><name><surname>Müller</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Increased mitochondrial mass and cytosolic redox imbalance in hippocampal astrocytes of a mouse model of Rett syndrome: subcellular changes revealed by ratiometric imaging of JC-1 and roGFP1 fluorescence.</article-title>
<source/><italic>Oxid Med. Cell Longev.</italic>
<volume>2017</volume>:<issue>3064016</issue>. <pub-id pub-id-type="pmid">28894505</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belichenko</surname><given-names>P. V.</given-names></name><name><surname>Wright</surname><given-names>E. E.</given-names></name><name><surname>Belichenko</surname><given-names>N. P.</given-names></name><name><surname>Masliah</surname><given-names>E.</given-names></name><name><surname>Li</surname><given-names>H. H.</given-names></name><name><surname>Mobley</surname><given-names>W. C.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks.</article-title>
<source/><italic>J. Compar. Neurol.</italic>
<volume>514</volume>
<fpage>240</fpage>–<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1002/cne.22009</pub-id>
<pub-id pub-id-type="pmid">19296534</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonini</surname><given-names>M. G.</given-names></name><name><surname>Rota</surname><given-names>C.</given-names></name><name><surname>Tomasi</surname><given-names>A.</given-names></name><name><surname>Mason</surname><given-names>R. P.</given-names></name></person-group> (<year>2006</year>). <article-title>The oxidation of 2′,7′-dichlorofluorescin to reactive oxygen species: a self-fulfilling prophesy?</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>40</volume>
<fpage>968</fpage>–<lpage>975</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2005.10.042</pub-id>
<pub-id pub-id-type="pmid">16540392</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boveris</surname><given-names>A.</given-names></name><name><surname>Chance</surname><given-names>B.</given-names></name></person-group> (<year>1973</year>). <article-title>The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen.</article-title>
<source/><italic>Biochem. J.</italic>
<volume>134</volume>
<fpage>707</fpage>–<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1042/bj1340707</pub-id>
<pub-id pub-id-type="pmid">4749271</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>M. D.</given-names></name></person-group> (<year>2010</year>). <article-title>The sites and topology of mitochondrial superoxide production.</article-title>
<source/><italic>Exp. Gerontol.</italic>
<volume>45</volume>
<fpage>466</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2010.01.003</pub-id>
<pub-id pub-id-type="pmid">20064600</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Can</surname><given-names>K.</given-names></name><name><surname>Kügler</surname><given-names>S.</given-names></name><name><surname>Müller</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>“Live imaging of mitochondrial ROS production and dynamic redox balance in neurons,” in</article-title>
<source/><italic>Techniques to Investigate Mitochondrial Function in Neurons</italic>, <role>eds</role>
<person-group person-group-type="editor"><name><surname>Strack</surname><given-names>S.</given-names></name><name><surname>Usachev</surname><given-names>Y. M.</given-names></name></person-group> (<publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>179</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-6890-9_9</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chahrour</surname><given-names>M.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>2007</year>). <article-title>The story of Rett syndrome: from clinic to neurobiology.</article-title>
<source/><italic>Neuron</italic>
<volume>56</volume>
<fpage>422</fpage>–<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.10.001</pub-id>
<pub-id pub-id-type="pmid">17988628</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.-C.</given-names></name><name><surname>Taylor</surname><given-names>E. B.</given-names></name><name><surname>Dephoure</surname><given-names>N.</given-names></name><name><surname>Heo</surname><given-names>J.-M.</given-names></name><name><surname>Tonhato</surname><given-names>A.</given-names></name><name><surname>Papandreou</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Identification of a protein mediating respiratory supercomplex stability.</article-title>
<source/><italic>Cell Metab.</italic>
<volume>15</volume>
<fpage>348</fpage>–<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2012.02.006</pub-id>
<pub-id pub-id-type="pmid">22405070</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coker</surname><given-names>S. B.</given-names></name><name><surname>Melnyk</surname><given-names>A. R.</given-names></name></person-group> (<year>1991</year>). <article-title>Rett syndrome and mitochondrial enzyme deficiencies.</article-title>
<source/><italic>J. Child Neurol.</italic>
<volume>6</volume>
<fpage>164</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1177/088307389100600216</pub-id>
<pub-id pub-id-type="pmid">1646255</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornford</surname><given-names>M. E.</given-names></name><name><surname>Philippart</surname><given-names>M.</given-names></name><name><surname>Jacobs</surname><given-names>B.</given-names></name><name><surname>Scheibel</surname><given-names>A. B.</given-names></name><name><surname>Vinters</surname><given-names>H. V.</given-names></name></person-group> (<year>1994</year>). <article-title>Neuropathology of Rett syndrome: case report with neuronal and mitochondrial abnormalities in the brain.</article-title>
<source/><italic>J. Child Neurol.</italic>
<volume>9</volume>
<fpage>424</fpage>–<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1177/088307389400900419</pub-id>
<pub-id pub-id-type="pmid">7822737</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Felice</surname><given-names>C.</given-names></name><name><surname>Ciccoli</surname><given-names>L.</given-names></name><name><surname>Leoncini</surname><given-names>S.</given-names></name><name><surname>Signorini</surname><given-names>C.</given-names></name><name><surname>Rossi</surname><given-names>M.</given-names></name><name><surname>Vannuccini</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Systemic oxidative stress in classic Rett syndrome.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>47</volume>
<fpage>440</fpage>–<lpage>448</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.05.016</pub-id>
<pub-id pub-id-type="pmid">19464363</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Felice</surname><given-names>C.</given-names></name><name><surname>Della Ragione</surname><given-names>F.</given-names></name><name><surname>Signorini</surname><given-names>C.</given-names></name><name><surname>Leoncini</surname><given-names>S.</given-names></name><name><surname>Pecorelli</surname><given-names>A.</given-names></name><name><surname>Ciccoli</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>68</volume>
<fpage>66</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.04.006</pub-id>
<pub-id pub-id-type="pmid">24769161</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Felice</surname><given-names>C.</given-names></name><name><surname>Signorini</surname><given-names>C.</given-names></name><name><surname>Leoncini</surname><given-names>S.</given-names></name><name><surname>Pecorelli</surname><given-names>A.</given-names></name><name><surname>Durand</surname><given-names>T.</given-names></name><name><surname>Valacchi</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>The role of oxidative stress in Rett syndrome: an overview.</article-title>
<source/><italic>Ann. N. Y. Acad. Sci.</italic>
<volume>1259</volume>
<fpage>121</fpage>–<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2012.06611.x</pub-id>
<pub-id pub-id-type="pmid">22758644</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Filippis</surname><given-names>B.</given-names></name><name><surname>Valenti</surname><given-names>D.</given-names></name><name><surname>De Bari</surname><given-names>L.</given-names></name><name><surname>De Rasmo</surname><given-names>D.</given-names></name><name><surname>Musto</surname><given-names>M.</given-names></name><name><surname>Fabbri</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Mitochondrial free radical overproduction due to respiratory chain impairment in the brain of a mouse model of Rett syndrome: protective effect of CNF1.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>83</volume>
<fpage>167</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.02.014</pub-id>
<pub-id pub-id-type="pmid">25708779</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dekker</surname><given-names>P. J.</given-names></name><name><surname>Martin</surname><given-names>F.</given-names></name><name><surname>Maarse</surname><given-names>A. C.</given-names></name><name><surname>Bömer</surname><given-names>U.</given-names></name><name><surname>Müller</surname><given-names>H.</given-names></name><name><surname>Guiard</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>The Tim core complex defines the number of mitochondrial translocation contact sites and can hold arrested preproteins in the absence of matrix Hsp70-Tim44.</article-title>
<source/><italic>EMBO J.</italic>
<volume>16</volume>
<fpage>5408</fpage>–<lpage>5419</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/16.17.5408</pub-id>
<pub-id pub-id-type="pmid">9312000</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiMauro</surname><given-names>S.</given-names></name><name><surname>Schon</surname><given-names>E. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Mitochondrial respiratory-chain diseases.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>348</volume>
<fpage>2656</fpage>–<lpage>2668</lpage>.<pub-id pub-id-type="pmid">12826641</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dooley</surname><given-names>C. T.</given-names></name><name><surname>Dore</surname><given-names>T. M.</given-names></name><name><surname>Hanson</surname><given-names>G. T.</given-names></name><name><surname>Jackson</surname><given-names>W. C.</given-names></name><name><surname>Remington</surname><given-names>S. J.</given-names></name><name><surname>Tsien</surname><given-names>R. Y.</given-names></name></person-group> (<year>2004</year>). <article-title>Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>279</volume>
<fpage>22284</fpage>–<lpage>22293</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m312847200</pub-id>
<pub-id pub-id-type="pmid">14985369</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dröse</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre- and postconditioning.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1827</volume>
<fpage>578</fpage>–<lpage>587</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2013.01.004</pub-id>
<pub-id pub-id-type="pmid">23333272</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudek</surname><given-names>J.</given-names></name><name><surname>Cheng</surname><given-names>I. F.</given-names></name><name><surname>Chowdhury</surname><given-names>A.</given-names></name><name><surname>Wozny</surname><given-names>K.</given-names></name><name><surname>Balleininger</surname><given-names>M.</given-names></name><name><surname>Reinhold</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Cardiac-specific succinate dehydrogenase deficiency in Barth syndrome.</article-title>
<source/><italic>EMBO Mol. Med.</italic>
<volume>8</volume>
<fpage>139</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.15252/emmm.201505644</pub-id>
<pub-id pub-id-type="pmid">26697888</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumay</surname><given-names>A.</given-names></name><name><surname>Rincheval</surname><given-names>V.</given-names></name><name><surname>Trotot</surname><given-names>P.</given-names></name><name><surname>Mignotte</surname><given-names>B.</given-names></name><name><surname>Vayssiere</surname><given-names>J. L.</given-names></name></person-group> (<year>2006</year>). <article-title>The superoxide dismutase inhibitor diethyldithiocarbamate has antagonistic effects on apoptosis by triggering both cytochrome c release and caspase inhibition.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>40</volume>
<fpage>1377</fpage>–<lpage>1390</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2005.12.005</pub-id>
<pub-id pub-id-type="pmid">16631528</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eeg-Olofsson</surname><given-names>O.</given-names></name><name><surname>Al-Zuhair</surname><given-names>A. G.</given-names></name><name><surname>Teebi</surname><given-names>A. S.</given-names></name><name><surname>Daoud</surname><given-names>A. S.</given-names></name><name><surname>Zaki</surname><given-names>M.</given-names></name><name><surname>Besisso</surname><given-names>M. S.</given-names></name><etal></etal></person-group> (<year>1990</year>). <article-title>Rett syndrome: a mitochondrial disease?</article-title>
<source/><italic>J. Child Neurol.</italic>
<volume>5</volume>
<fpage>210</fpage>–<lpage>214</lpage>.<pub-id pub-id-type="pmid">2168910</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>M.</given-names></name><name><surname>Reuter</surname><given-names>J.</given-names></name><name><surname>Gerich</surname><given-names>F. J.</given-names></name><name><surname>Hildebrandt</surname><given-names>B.</given-names></name><name><surname>Hägele</surname><given-names>S.</given-names></name><name><surname>Katschinski</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Enhanced hypoxia susceptibility in hippocampal slices from a mouse model of Rett syndrome.</article-title>
<source/><italic>J Neurophysiol.</italic>
<volume>101</volume>
<fpage>1016</fpage>–<lpage>1032</lpage>. <pub-id pub-id-type="doi">10.1152/jn.91124.2008</pub-id>
<pub-id pub-id-type="pmid">19073793</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funke</surname><given-names>F.</given-names></name><name><surname>Gerich</surname><given-names>F. J.</given-names></name><name><surname>Müller</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Dynamic, semi-quantitative imaging of intracellular ROS levels and redox status in rat hippocampal neurons.</article-title>
<source/><italic>Neuroimage</italic>
<volume>54</volume>
<fpage>2590</fpage>–<lpage>2602</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.11.031</pub-id>
<pub-id pub-id-type="pmid">21081169</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>J. H.</given-names></name><name><surname>Slobedman</surname><given-names>B. K. N. H.</given-names></name><name><surname>Williamson</surname><given-names>S. L.</given-names></name><name><surname>Minchenko</surname><given-names>D.</given-names></name><name><surname>El-Osta</surname><given-names>A.</given-names></name></person-group><etal></etal> (<year>2010</year>). <article-title>Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain.</article-title>
<source/><italic>BMC Neurosci.</italic>
<volume>11</volume>:<issue>53</issue>. <pub-id pub-id-type="doi">10.1186/1471-2202-11-53</pub-id>
<pub-id pub-id-type="pmid">20420693</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>W. A.</given-names></name><name><surname>Williamson</surname><given-names>S. L.</given-names></name><name><surname>Kaur</surname><given-names>S.</given-names></name><name><surname>Hargreaves</surname><given-names>I. P.</given-names></name><name><surname>Land</surname><given-names>J. M.</given-names></name><name><surname>Pelka</surname><given-names>G. J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Mitochondrial dysfunction in the skeletal muscle of a mouse model of Rett syndrome (RTT): implications for the disease phenotype.</article-title>
<source/><italic>Mitochondrion</italic>
<volume>15</volume>
<fpage>10</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2014.02.012</pub-id>
<pub-id pub-id-type="pmid">24613463</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Großer</surname><given-names>E.</given-names></name><name><surname>Hirt</surname><given-names>U.</given-names></name><name><surname>Janc</surname><given-names>O. A.</given-names></name><name><surname>Menzfeld</surname><given-names>C.</given-names></name><name><surname>Fischer</surname><given-names>M.</given-names></name><name><surname>Kempkes</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>48</volume>
<fpage>102</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2012.06.007</pub-id>
<pub-id pub-id-type="pmid">22750529</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guy</surname><given-names>J.</given-names></name><name><surname>Hendrich</surname><given-names>B.</given-names></name><name><surname>Holmes</surname><given-names>M.</given-names></name><name><surname>Martin</surname><given-names>J. E.</given-names></name><name><surname>Bird</surname><given-names>A.</given-names></name></person-group> (<year>2001</year>). <article-title>A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>27</volume>
<fpage>322</fpage>–<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1038/85899</pub-id>
<pub-id pub-id-type="pmid">11242117</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagberg</surname><given-names>B.</given-names></name><name><surname>Aicardi</surname><given-names>J.</given-names></name><name><surname>Dias</surname><given-names>K.</given-names></name><name><surname>Ramos</surname><given-names>O.</given-names></name></person-group> (<year>1983</year>). <article-title>A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>14</volume>
<fpage>471</fpage>–<lpage>479</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410140412</pub-id>
<pub-id pub-id-type="pmid">6638958</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>G. T.</given-names></name><name><surname>Aggeler</surname><given-names>R.</given-names></name><name><surname>Oglesbee</surname><given-names>D.</given-names></name><name><surname>Cannon</surname><given-names>M.</given-names></name><name><surname>Capaldi</surname><given-names>R. A.</given-names></name><name><surname>Tsien</surname><given-names>R. Y.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>279</volume>
<fpage>13044</fpage>–<lpage>13053</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m312846200</pub-id>
<pub-id pub-id-type="pmid">14722062</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>J.</given-names></name><name><surname>Whitney</surname><given-names>P.</given-names></name></person-group> (<year>1991</year>). <article-title>Use of cyanide and diethyldithiocarbamate in the assay of superoxide dismutases.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>10</volume>
<fpage>69</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/0891-5849(91)90023-v</pub-id><pub-id pub-id-type="pmid">1646752</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>L. W.</given-names></name><name><surname>Horiuchi</surname><given-names>M.</given-names></name><name><surname>Wulff</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>X. B.</given-names></name><name><surname>Cortopassi</surname><given-names>G. A.</given-names></name><name><surname>Erickson</surname><given-names>J. D.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>35</volume>
<fpage>2516</fpage>–<lpage>2529</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2778-14.2015</pub-id>
<pub-id pub-id-type="pmid">25673846</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalyanaraman</surname><given-names>B.</given-names></name><name><surname>Darley-Usmar</surname><given-names>V.</given-names></name><name><surname>Davies</surname><given-names>K. J.</given-names></name><name><surname>Dennery</surname><given-names>P. A.</given-names></name><name><surname>Forman</surname><given-names>H. J.</given-names></name><name><surname>Grisham</surname><given-names>M. B.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>52</volume>
<fpage>1</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.09.030</pub-id>
<pub-id pub-id-type="pmid">22027063</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komary</surname><given-names>Z.</given-names></name><name><surname>Tretter</surname><given-names>L.</given-names></name><name><surname>Adam-Vizi</surname><given-names>V.</given-names></name></person-group> (<year>2010</year>). <article-title>Membrane potential-related effect of calcium on reactive oxygen species generation in isolated brain mitochondria.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1797</volume>
<fpage>922</fpage>–<lpage>928</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2010.03.010</pub-id>
<pub-id pub-id-type="pmid">20230776</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kriaucionis</surname><given-names>S.</given-names></name><name><surname>Paterson</surname><given-names>A.</given-names></name><name><surname>Curtis</surname><given-names>J.</given-names></name><name><surname>Guy</surname><given-names>J.</given-names></name><name><surname>Macleod</surname><given-names>N.</given-names></name><name><surname>Bird</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome.</article-title>
<source/><italic>Mol. Cell. Biol.</italic>
<volume>26</volume>
<fpage>5033</fpage>–<lpage>5042</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.01665-05</pub-id>
<pub-id pub-id-type="pmid">16782889</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenaz</surname><given-names>G.</given-names></name><name><surname>Genova</surname><given-names>M. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Supramolecular organisation of the mitochondrial respiratory chain: a new challenge for the mechanism and control of oxidative phosphorylation.</article-title>
<source/><italic>Adv. Exp. Med. Biol.</italic>
<volume>748</volume>
<fpage>107</fpage>–<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4614-3573-0_5</pub-id>
<pub-id pub-id-type="pmid">22729856</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Muffat</surname><given-names>J.</given-names></name><name><surname>Cheng</surname><given-names>A. W.</given-names></name><name><surname>Orlando</surname><given-names>D. A.</given-names></name><name><surname>Loven</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons.</article-title>
<source/><italic>Cell Stem Cell</italic>
<volume>13</volume>
<fpage>446</fpage>–<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2013.09.001</pub-id>
<pub-id pub-id-type="pmid">24094325</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattiasson</surname><given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>Analysis of mitochondrial generation and release of reactive oxygen species.</article-title>
<source/><italic>Cytometry A</italic>
<volume>62</volume>
<fpage>89</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1002/cyto.a.20089</pub-id>
<pub-id pub-id-type="pmid">15517564</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLennan</surname><given-names>H. R.</given-names></name><name><surname>Degli Esposti</surname><given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species.</article-title>
<source/><italic>J. Bioenergy Biomembr.</italic>
<volume>32</volume>
<fpage>153</fpage>–<lpage>162</lpage>.</mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>A. J.</given-names></name><name><surname>Dick</surname><given-names>T. P.</given-names></name></person-group> (<year>2010</year>). <article-title>Fluorescent protein-based redox probes.</article-title>
<source/><italic>Antioxid. Redox Signal.</italic>
<volume>13</volume>
<fpage>621</fpage>–<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2009.2948</pub-id>
<pub-id pub-id-type="pmid">20088706</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>P.</given-names></name></person-group> (<year>1961</year>). <article-title>Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism.</article-title>
<source/><italic>Nature</italic>
<volume>191</volume>
<fpage>144</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1038/191144a0</pub-id>
<pub-id pub-id-type="pmid">13771349</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Disturbed redox homeostasis and oxidative stress: potential players in the developmental regression in Rett syndrome.</article-title>
<source/><italic>Neurosci. Biobehav. Rev.</italic>
<volume>98</volume>
<fpage>154</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2018.12.009</pub-id>
<pub-id pub-id-type="pmid">30639673</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>M.</given-names></name><name><surname>Can</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>Aberrant redox homoeostasis and mitochondrial dysfunction in Rett syndrome.</article-title>
<source/><italic>Biochem. Soc. Trans.</italic>
<volume>42</volume>
<fpage>959</fpage>–<lpage>964</lpage>. <pub-id pub-id-type="doi">10.1042/bst20140071</pub-id>
<pub-id pub-id-type="pmid">25109986</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholls</surname><given-names>D. G.</given-names></name><name><surname>Locke</surname><given-names>R. M.</given-names></name></person-group> (<year>1984</year>). <article-title>Thermogenic mechanisms in brown fat.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>64</volume>
<fpage>1</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.1984.64.1.1</pub-id>
<pub-id pub-id-type="pmid">6320232</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheu-Grau</surname><given-names>D.</given-names></name><name><surname>Bareth</surname><given-names>B.</given-names></name><name><surname>Dudek</surname><given-names>J.</given-names></name><name><surname>Juris</surname><given-names>L.</given-names></name><name><surname>Vögtle</surname><given-names>F. N.</given-names></name><name><surname>Wissel</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Cooperation between COA6 and SCO2 in COX2 maturation during cytochrome c oxidase assembly links two mitochondrial cardiomyopathies.</article-title>
<source/><italic>Cell Metab.</italic>
<volume>21</volume>
<fpage>823</fpage>–<lpage>833</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2015.04.012</pub-id>
<pub-id pub-id-type="pmid">25959673</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>M. J.</given-names></name><name><surname>Aja</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Degano</surname><given-names>A. L.</given-names></name><name><surname>Penati</surname><given-names>J.</given-names></name><name><surname>Zhuo</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e109527</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0109527</pub-id>
<pub-id pub-id-type="pmid">25299635</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pecorelli</surname><given-names>A.</given-names></name><name><surname>Leoni</surname><given-names>G.</given-names></name><name><surname>Cervellati</surname><given-names>F.</given-names></name><name><surname>Canali</surname><given-names>R.</given-names></name><name><surname>Signorini</surname><given-names>C.</given-names></name><name><surname>Leoncini</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Genes related to mitochondrial functions, protein degradation, and chromatin folding are differentially expressed in lymphomonocytes of Rett syndrome patients.</article-title>
<source/><italic>Mediat. Inflamm.</italic>
<volume>2013</volume>:<issue>137629</issue>. <pub-id pub-id-type="pmid">24453408</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rett</surname><given-names>A.</given-names></name></person-group> (<year>1966</year>). <article-title>Über ein eigenartiges hirnatrophisches syndrom bei hyperammonämie im Kindesalter.</article-title>
<source/><italic>Wien Med. Wochenschr.</italic>
<volume>116</volume>
<fpage>723</fpage>–<lpage>726</lpage>.<pub-id pub-id-type="pmid">5300597</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricquier</surname><given-names>D.</given-names></name><name><surname>Bouillaud</surname><given-names>F.</given-names></name></person-group> (<year>2000</year>). <article-title>Mitochondrial uncoupling proteins: from mitochondria to the regulation of energy balance.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>529</volume>
<fpage>3</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.2000.00003.x</pub-id><pub-id pub-id-type="pmid">11080246</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rönnbäck</surname><given-names>A.</given-names></name><name><surname>Pavlov</surname><given-names>P. F.</given-names></name><name><surname>Mansory</surname><given-names>M.</given-names></name><name><surname>Gonze</surname><given-names>P.</given-names></name><name><surname>Marlière</surname><given-names>N.</given-names></name><name><surname>Winblad</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Mitochondrial dysfunction in a transgenic mouse model expressing human amyloid precursor protein (APP) with the Arctic mutation.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>136</volume>
<fpage>497</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13410</pub-id>
<pub-id pub-id-type="pmid">26500157</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossignol</surname><given-names>D. A.</given-names></name><name><surname>Frye</surname><given-names>R. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>17</volume>
<fpage>290</fpage>–<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2010.136</pub-id>
<pub-id pub-id-type="pmid">21263444</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rota</surname><given-names>C.</given-names></name><name><surname>Chignell</surname><given-names>C. F.</given-names></name><name><surname>Mason</surname><given-names>R. P.</given-names></name></person-group> (<year>1999</year>). <article-title>Evidence for free radical formation during the oxidation of 2′-7′-dichlorofluorescin to the fluorescent dye 2′-7′-dichlorofluorescein by horseradish peroxidase: possible implications for oxidative stress measurements.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>27</volume>
<fpage>873</fpage>–<lpage>881</lpage>. <pub-id pub-id-type="doi">10.1016/s0891-5849(99)00137-9</pub-id><pub-id pub-id-type="pmid">10515592</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruch</surname><given-names>A.</given-names></name><name><surname>Kurczynski</surname><given-names>T. W.</given-names></name><name><surname>Velasco</surname><given-names>M. E.</given-names></name></person-group> (<year>1989</year>). <article-title>Mitochondrial alterations in Rett syndrome.</article-title>
<source/><italic>Pediatr. Neurol.</italic>
<volume>5</volume>
<fpage>320</fpage>–<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1016/0887-8994(89)90027-1</pub-id><pub-id pub-id-type="pmid">2803392</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saywell</surname><given-names>V.</given-names></name><name><surname>Viola</surname><given-names>A.</given-names></name><name><surname>Confort-Gouny</surname><given-names>S.</given-names></name><name><surname>Le Fur</surname><given-names>Y.</given-names></name><name><surname>Villard</surname><given-names>L.</given-names></name><name><surname>Cozzone</surname><given-names>P. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Brain magnetic resonance study of Mecp2 deletion effects on anatomy and metabolism.</article-title>
<source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>340</volume>
<fpage>776</fpage>–<lpage>783</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2005.12.080</pub-id>
<pub-id pub-id-type="pmid">16380085</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schägger</surname><given-names>H.</given-names></name><name><surname>Pfeiffer</surname><given-names>K.</given-names></name></person-group> (<year>2000</year>). <article-title>Supercomplexes in the respiratory chains of yeast and mammalian mitochondria.</article-title>
<source/><italic>EMBO J.</italic>
<volume>19</volume>
<fpage>1777</fpage>–<lpage>1783</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/19.8.1777</pub-id><pub-id pub-id-type="pmid">10775262</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shulyakova</surname><given-names>N.</given-names></name><name><surname>Andreazza</surname><given-names>A. C.</given-names></name><name><surname>Mills</surname><given-names>L. R.</given-names></name><name><surname>Eubanks</surname><given-names>J. H.</given-names></name></person-group> (<year>2017</year>). <article-title>Mitochondrial dysfunction in the pathogenesis of Rett syndrome: implications for mitochondria-targeted therapies.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>11</volume>:<issue>58</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2017.00058</pub-id>
<pub-id pub-id-type="pmid">28352216</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sierra</surname><given-names>C.</given-names></name><name><surname>Vilaseca</surname><given-names>M. A.</given-names></name><name><surname>Brandi</surname><given-names>N.</given-names></name><name><surname>Artuch</surname><given-names>R.</given-names></name><name><surname>Mira</surname><given-names>A.</given-names></name><name><surname>Nieto</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Oxidative stress in Rett syndrome.</article-title>
<source/><italic>Brain Dev.</italic>
<volume>23(Suppl. 1)</volume>, <fpage>S236</fpage>–<lpage>S239</lpage>.<pub-id pub-id-type="pmid">11738881</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoppini</surname><given-names>L.</given-names></name><name><surname>Buchs</surname><given-names>P. A.</given-names></name><name><surname>Muller</surname><given-names>D.</given-names></name></person-group> (<year>1991</year>). <article-title>A simple method for organotypic cultures of nervous tissue.</article-title>
<source/><italic>J. Neurosci. Methods</italic>
<volume>37</volume>
<fpage>173</fpage>–<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1016/0165-0270(91)90128-m</pub-id><pub-id pub-id-type="pmid">1715499</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toloe</surname><given-names>J.</given-names></name><name><surname>Mollajew</surname><given-names>R.</given-names></name><name><surname>Kügler</surname><given-names>S.</given-names></name><name><surname>Mironov</surname><given-names>S. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Metabolic differences in hippocampal ‘Rett’ neurons revealed by ATP imaging.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>59C</volume>, <fpage>47</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2013.12.008</pub-id>
<pub-id pub-id-type="pmid">24394521</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valenti</surname><given-names>D.</given-names></name><name><surname>De Bari</surname><given-names>L.</given-names></name><name><surname>De Filippis</surname><given-names>B.</given-names></name><name><surname>Henrion-Caude</surname><given-names>A.</given-names></name><name><surname>Vacca</surname><given-names>R. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome.</article-title>
<source/><italic>Neurosci. Biobehav. Rev.</italic>
<volume>46(Pt 2)</volume>, <fpage>202</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2014.01.012</pub-id>
<pub-id pub-id-type="pmid">24548784</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valenti</surname><given-names>D.</given-names></name><name><surname>De Bari</surname><given-names>L.</given-names></name><name><surname>Vigli</surname><given-names>D.</given-names></name><name><surname>Lacivita</surname><given-names>E.</given-names></name><name><surname>Leopoldo</surname><given-names>M.</given-names></name><name><surname>Laviola</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndrome.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>121</volume>
<fpage>79</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2017.04.024</pub-id>
<pub-id pub-id-type="pmid">28419872</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Votyakova</surname><given-names>T. V.</given-names></name><name><surname>Reynolds</surname><given-names>I. J.</given-names></name></person-group> (<year>2001</year>). <article-title>ΔΨm-dependent and -independent production of reactive oxygen species by rat brain mitochondria.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>79</volume>
<fpage>266</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2001.00548.x</pub-id><pub-id pub-id-type="pmid">11677254</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vukotic</surname><given-names>M.</given-names></name><name><surname>Oeljeklaus</surname><given-names>S.</given-names></name><name><surname>Wiese</surname><given-names>S.</given-names></name><name><surname>Vogtle</surname><given-names>F. N.</given-names></name><name><surname>Meisinger</surname><given-names>C.</given-names></name><name><surname>Meyer</surname><given-names>H. E.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Rcf1 mediates cytochrome oxidase assembly and respirasome formation, revealing heterogeneity of the enzyme complex.</article-title>
<source/><italic>Cell Metab.</italic>
<volume>15</volume>
<fpage>336</fpage>–<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2012.01.016</pub-id>
<pub-id pub-id-type="pmid">22342701</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagener</surname><given-names>K. C.</given-names></name><name><surname>Kolbrink</surname><given-names>B.</given-names></name><name><surname>Dietrich</surname><given-names>K.</given-names></name><name><surname>Kizina</surname><given-names>K. M.</given-names></name><name><surname>Terwitte</surname><given-names>L. S.</given-names></name><name><surname>Kempkes</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Redox-indicator mice stably expressing genetically-encoded neuronal roGFP: versatile tools to decipher subcellular redox dynamics in neuropathophysiology.</article-title>
<source/><italic>Antioxid. Redox Signal.</italic>
<volume>25</volume>
<fpage>41</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2015.6587</pub-id>
<pub-id pub-id-type="pmid">27059697</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>D. C.</given-names></name></person-group> (<year>1999</year>). <article-title>Mitochondrial diseases in man and mouse.</article-title>
<source/><italic>Science</italic>
<volume>283</volume>
<fpage>1482</fpage>–<lpage>1488</lpage>. <pub-id pub-id-type="doi">10.1126/science.283.5407.1482</pub-id><pub-id pub-id-type="pmid">10066162</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wardman</surname><given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>43</volume>
<fpage>995</fpage>–<lpage>1022</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2007.06.026</pub-id>
<pub-id pub-id-type="pmid">17761297</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waypa</surname><given-names>G. B.</given-names></name><name><surname>Marks</surname><given-names>J. D.</given-names></name><name><surname>Guzy</surname><given-names>R.</given-names></name><name><surname>Mungai</surname><given-names>P. T.</given-names></name><name><surname>Schriewer</surname><given-names>J.</given-names></name><name><surname>Dokic</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Hypoxia triggers subcellular compartmental redox signaling in vascular smooth muscle cells.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>106</volume>
<fpage>526</fpage>–<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1161/circresaha.109.206334</pub-id>
<pub-id pub-id-type="pmid">20019331</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weerapana</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Simon</surname><given-names>G. M.</given-names></name><name><surname>Richter</surname><given-names>F.</given-names></name><name><surname>Khare</surname><given-names>S.</given-names></name><name><surname>Dillon</surname><given-names>M. B.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Quantitative reactivity profiling predicts functional cysteines in proteomes.</article-title>
<source/><italic>Nature</italic>
<volume>468</volume>
<fpage>790</fpage>–<lpage>795</lpage>. <pub-id pub-id-type="doi">10.1038/nature09472</pub-id>
<pub-id pub-id-type="pmid">21085121</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittig</surname><given-names>I.</given-names></name><name><surname>Braun</surname><given-names>H. P.</given-names></name><name><surname>Schagger</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>Blue native PAGE.</article-title>
<source/><italic>Nat. Protoc.</italic>
<volume>1</volume>
<fpage>418</fpage>–<lpage>428</lpage>.<pub-id pub-id-type="pmid">17406264</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittig</surname><given-names>I.</given-names></name><name><surname>Karas</surname><given-names>M.</given-names></name><name><surname>Schagger</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>High resolution clear native electrophoresis for in-gel functional assays and fluorescence studies of membrane protein complexes.</article-title>
<source/><italic>Mol. Cell. Proteom.</italic>
<volume>6</volume>
<fpage>1215</fpage>–<lpage>1225</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.m700076-mcp200</pub-id>
<pub-id pub-id-type="pmid">17426019</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>M.</given-names></name><name><surname>Gu</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>R.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Structure of mammalian respiratory supercomplex I1III2IV1.</article-title>
<source/><italic>Cell</italic>
<volume>167</volume>:<issue>e1510</issue>.</mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zerbetto</surname><given-names>E.</given-names></name><name><surname>Vergani</surname><given-names>L.</given-names></name><name><surname>Dabbeni-Sala</surname><given-names>F.</given-names></name></person-group> (<year>1997</year>). <article-title>Quantification of muscle mitochondrial oxidative phosphorylation enzymes via histochemical staining of blue native polyacrylamide gels.</article-title>
<source/><italic>Electrophoresis</italic>
<volume>18</volume>
<fpage>2059</fpage>–<lpage>2064</lpage>. <pub-id pub-id-type="doi">10.1002/elps.1150181131</pub-id>
<pub-id pub-id-type="pmid">9420170</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Diwu</surname><given-names>Z.</given-names></name><name><surname>Panchuk-Voloshina</surname><given-names>N.</given-names></name><name><surname>Haugland</surname><given-names>R. P.</given-names></name></person-group> (<year>1997</year>). <article-title>A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases.</article-title>
<source/><italic>Anal. Biochem.</italic>
<volume>253</volume>
<fpage>162</fpage>–<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1006/abio.1997.2391</pub-id>
<pub-id pub-id-type="pmid">9367498</pub-id></mixed-citation>
</ref>
</ref-list>
<glossary>
<title>Abbreviations</title>
<def-list id="DL1">
<def-item>
<term>ACSF</term>
<def>
<p>artificial cerebrospinal fluid</p>
</def>
</def-item>
<def-item>
<term>AMC</term>
<def>
<p>antimycin A</p>
</def>
</def-item>
<def-item>
<term>ATP5B</term>
<def>
<p>ATP synthase subunit beta</p>
</def>
</def-item>
<def-item>
<term>BN-PAGE</term>
<def>
<p>blue native polyacrylamide gel electrophoresis</p>
</def>
</def-item>
<def-item>
<term>CI complex I</term>
<def>
<p>NADH dehydrogenase</p>
</def>
</def-item>
<def-item>
<term>CII complex II</term>
<def>
<p>succinate dehydrogenase</p>
</def>
</def-item>
<def-item>
<term>CIII complex III</term>
<def>
<p>coenzyme Q-cytochrome <italic>c</italic> reductase</p>
</def>
</def-item>
<def-item>
<term>CIV complex IV</term>
<def>
<p>cytochrome <italic>c</italic> oxidase</p>
</def>
</def-item>
<def-item>
<term>CV complex IV</term>
<def>
<p>ATP synthase F<sub>1</sub>F<sub>o</sub>-ATPase</p>
</def>
</def-item>
<def-item>
<term>DEDTC</term>
<def>
<p>diethyldithiocarbamic acid</p>
</def>
</def-item>
<def-item>
<term>DIV</term>
<def>
<p>days <italic>in vitro</italic></p>
</def>
</def-item>
<def-item>
<term>DTT</term>
<def>
<p>1,4-dithio-DL-threitol</p>
</def>
</def-item>
<def-item>
<term>E<sub>roGFP1</sub></term>
<def>
<p>roGFP1 reduction potential</p>
</def>
</def-item>
<def-item>
<term>FCCP</term>
<def>
<p>carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone</p>
</def>
</def-item>
<def-item>
<term>F<sub>1</sub>F<sub>o</sub>-ATPase</term>
<def>
<p>ATP synthase, complex V</p>
</def>
</def-item>
<def-item>
<term>GAPDH</term>
<def>
<p>glyceraldehyde-3-phosphate dehydrogenase</p>
</def>
</def-item>
<def-item>
<term>GSH</term>
<def>
<p>reduced glutathione</p>
</def>
</def-item>
<def-item>
<term>H<sub>2</sub>DCFDA</term>
<def>
<p>2′,7′-dichlorodihydrofluorescein diacetate</p>
</def>
</def-item>
<def-item>
<term>HBSS</term>
<def>
<p>Hanks’-balanced salt solution</p>
</def>
</def-item>
<def-item>
<term>HEPES</term>
<def>
<p>4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid</p>
</def>
</def-item>
<def-item>
<term>MAS</term>
<def>
<p>mitochondrial assay solution</p>
</def>
</def-item>
<def-item>
<term>MeCP2</term>
<def>
<p>methyl-CpG binding protein 2, protein</p>
</def>
</def-item>
<def-item>
<term>
<italic>MECP2</italic>
</term>
<def>
<p>methyl-CpG binding protein 2, encoding gene (human)</p>
</def>
</def-item>
<def-item>
<term>
<italic>Mecp2</italic>
</term>
<def>
<p>methyl-CpG binding protein 2, encoding gene (mouse)</p>
</def>
</def-item>
<def-item>
<term>
<italic>Mecp2<sup>-/y</sup></italic>
</term>
<def>
<p>MeCP2-deficient male mouse (hemizygous)</p>
</def>
</def-item>
<def-item>
<term>
<italic>Mecp2<sup>+/-</sup></italic>
</term>
<def>
<p>MeCP2-deficient female mouse (heterozygous)</p>
</def>
</def-item>
<def-item>
<term>NDUFB8</term>
<def>
<p>NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8</p>
</def>
</def-item>
<def-item>
<term>NTB</term>
<def>
<p>nitrotetrazolium blue</p>
</def>
</def-item>
<def-item>
<term>OxD<sub>roGFP1</sub></term>
<def>
<p>relative degree of roGFP1 oxidation</p>
</def>
</def-item>
<def-item>
<term>PD</term>
<def>
<p>postnatal day</p>
</def>
</def-item>
<def-item>
<term>PMSF</term>
<def>
<p>phenylmethyl-sulfonyl fluoride</p>
</def>
</def-item>
<def-item>
<term>roGFP1</term>
<def>
<p>reduction-oxidation sensitive green fluorescent protein 1</p>
</def>
</def-item>
<def-item>
<term>ROS</term>
<def>
<p>reactive oxygen species</p>
</def>
</def-item>
<def-item>
<term>R</term>
<def>
<p>fluorescence ratio (F<sub>395</sub>/F<sub>470</sub>)</p>
</def>
</def-item>
<def-item>
<term>R<sub>ox</sub></term>
<def>
<p>ratio corresponding to full oxidation</p>
</def>
</def-item>
<def-item>
<term>R<sub>red</sub></term>
<def>
<p>ratio corresponding to full reduction</p>
</def>
</def-item>
<def-item>
<term>RTT</term>
<def>
<p>Rett syndrome</p>
</def>
</def-item>
<def-item>
<term>SDHA</term>
<def>
<p>succinate dehydrogenase subunit A</p>
</def>
</def-item>
<def-item>
<term>SDS-PAGE</term>
<def>
<p>sodium dodecyl sulfate polyacrylamide gel electrophoresis</p>
</def>
</def-item>
<def-item>
<term>SOD1</term>
<def>
<p>Cu/Zn superoxide dismutase</p>
</def>
</def-item>
<def-item>
<term>TBS</term>
<def>
<p>Tris-buffered saline</p>
</def>
</def-item>
<def-item>
<term>WT</term>
<def>
<p>wildtype</p>
</def>
</def-item>
<def-item>
<term>VDAC3</term>
<def>
<p>voltage-dependent anion channel 3</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>
</pmc-articleset>